US20170035433A1 - Left atrial appendage occluder device anchoring system, anchor, and method of attachment - Google Patents
Left atrial appendage occluder device anchoring system, anchor, and method of attachment Download PDFInfo
- Publication number
- US20170035433A1 US20170035433A1 US14/819,724 US201514819724A US2017035433A1 US 20170035433 A1 US20170035433 A1 US 20170035433A1 US 201514819724 A US201514819724 A US 201514819724A US 2017035433 A1 US2017035433 A1 US 2017035433A1
- Authority
- US
- United States
- Prior art keywords
- anchor
- laa
- occluder device
- layer
- wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00349—Needle-like instruments having hook or barb-like gripping means, e.g. for grasping suture or tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
Definitions
- the present invention relates in general to an anchoring system and method of attaching and retrieving an occluder device in the left atrial appendage of the heart.
- the purpose of the invention is to provide an anchoring system and method of attaching and retrieving an occluder device that ensures optimal placement within the left atrial appendage of the heart.
- a further purpose of the present invention is to provide an anchor for an occluder device that has a low risk of embolization.
- LAA non-valvular atrial fibrillation involving complications with the left atrial appendage of the heart
- the LAA is a small, windsock shaped sac in the muscle wall of the left atrium. Though uncertain as to what function the LAA performs, if anything, what is certain is that in patients with non-valvular atrial fibrillation, 90% of the thrombus formation occurs in the body of the LAA.
- electrical impulses that control a heartbeat travel in an orderly fashion throughout the heart. These electrical impulses cause the heart to contract wherein blood in the left atrium and LAA is driven into the left ventricle with each heartbeat.
- Treatment of atrial fibrillation typically involves oral anticoagulant therapy.
- Patient's taking blood thinners have noted a reduction in the risk of stroke by 65% as compared to patients without medication.
- the oral anticoagulant warfarin (COUMADIN®) has been traditionally utilized to minimize thrombus formation in patients with atrial fibrillation. Due to the requirement of frequent blood draws to monitor a patient's anticoagulation status, frequent interactions of the medication with either dietary changes or with other medications, and the high risk of encountering serious bleeding events, Coumadin has recently fallen into disfavor in the medical community.
- Newer medications including dabigatran (PRADAXA®) and rivaroxaban (XARELTO®) are also being utilized. The advantage of these newer medications are that they have less interaction with dietary changes and do not require blood draws to monitor a patient's anticoagulation status. However, these medications continue to encounter serious gastrointestinal bleeding events, are not reversible, and are extremely expensive.
- LAA occlusion involves implanting a device into the heart that closes the LAA.
- occluder devices including the WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and the AMULETTM.
- WATCHMAN® WATCHMAN®
- ATRICLIP® PLAATO LAA Occlusion System®
- PLAATO LAA Occlusion System® PLAATO LAA Occlusion System®
- AMPLATZERTM AMPLATZERTM
- AMULETTM the major technical difficulty encountered is to get the device to reliably fix itself within the LAA without embolizing or migrating out of the LAA into the systemic circulation.
- the heart is comprised of three layers: (1) an inner endocardium layer; (2) a middle myocardium layer; and (3) an outer epicardium layer.
- the endocardium is a fragile, thin layer of tissue that lines the heart's chambers and valves.
- the myocardium is the thickest layer of the heart and is comprised of muscle tissue.
- the epicardium is a thin layer of visceral tissue.
- Between the heart and mediastinal space is the pericardium.
- the pericardium is a visceral layer of endothelium.
- the pericardial space lies in between the heart's epicardial surface and the pericardium.
- the pericardial space is filled with clear fluid that minimizes friction between the heart and other structures within the chest wall.
- occluder device embolizes out of the LAA
- irreparable damage to neighboring structures such as the mitral and/or aortic valves of the heart may occur in part, due to the presence of the barbs on the occluder device.
- Retrieval of an embolized occluder device is further complicated by the presence of the retention barbs.
- an anchoring system and method for implanting an occluder device in the LAA that would allow for complete retraction and removal of the occluder device without permanently damaging the device.
- an anchoring system and method for implanting an occluder device in the LAA that provides a low risk of embolization and/or causing injury to neighboring valve structures.
- an anchoring system and method for implanting an occluder device that allows the occluder device to be positioned in multiple locations within the LAA, being able to be used in all types of LAA anatomy, and still result in optimal final placement of the occluder device within the LAA.
- a further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting and retrieving an occluder device in the LAA that may be used with a diverse range of LAA occluder devices.
- Another object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting and recapturing an occluder device in the LAA that minimizes the risk of the occluder device embolizing or migrating following release of the occluder device into the LAA.
- Yet another object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that allows an interventional cardiologist to anchor the occluder device in multiple locations within the LAA.
- a still further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that allows the occluder device to be retrieved and adjusted within the LAA to achieve an optimal final position.
- Another object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that causes minimal or no bleeding into the pericardial space upon anchoring.
- a further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that is easy to implant and retrieve by an interventional cardiologist.
- a still further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that allows the occluder device to be retrieved and adjusted by a interventional cardiologist within the LAA without damaging the occluder device.
- an anchoring system for implanting and retrieving an occluder device into a LAA comprises an outer sheath and a pericardial catheter.
- the pericardial catheter may be advanced through the outer sheath into the LAA, wherein the pericardial catheter penetrates a wall of the LAA and enters the pericardial space creating a small hole.
- a buddy wire and/or a delivery wire are advanced through the pericardial catheter to enter the pericardial space.
- the anchoring system of the present invention further comprises an anchor, an occluder device, and a flexible connector.
- the occluder device may be attached to the anchor via the connector.
- the anchor, the connector, and the occluder device are advanced through the outer sheath.
- the anchor is further advanced to penetrate the LAA wall via the small hole and extend into the pericardial space. Specifically, the anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall. Once inside the pericardial space, the anchor self-expands to implant the base in the LAA wall.
- the anchor is further configured to prevent the occluder device from being pushed through the small hole into the pericardial space. The outer sheath releases the occluder device into the LAA, wherein it is held in position by the anchor.
- Another aspect of the present invention includes a method of implanting and retrieving an occluder device into a LAA using the anchoring system described above.
- an anchoring system for implanting and retrieving an occluder device into a LAA comprises an outer sheath, a pericardial catheter, an occluder device, and an anchor.
- the pericardial catheter may be advanced through the outer sheath into the LAA, wherein the pericardial catheter penetrates a wall of the LAA and enters the pericardial space creating a small hole.
- the anchor may comprise a sheave shape with a first half and a second half connected by a shaft.
- the anchor may further comprise a contracted first position and a deployed second position.
- the occluder device, anchor catheter, and anchor are advanced through the outer sheath using the delivery wire, wherein the anchor is in the contracted first position.
- the anchor catheter is further advanced to penetrate the LAA wall via the small hole and extend into the pericardial space.
- the anchor catheter delivers the anchor, wherein the first half of the anchor remains inside the LAA and the shaft portion and the second half of the anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall.
- the second half of the anchor self-expands to the deployed second position within the pericardial space to implant the anchor in the LAA wall.
- the first half of the anchor remaining within the LAA also self-expands to the deployed second position, pinning the occluder device against the wall of the LAA.
- the outer sheath releases the occluder device into the LAA, wherein it is held in position by the anchor.
- a method of implanting and retrieving an occluder device into a LAA is provided.
- Another aspect of the present invention includes a method of implanting and retrieving an occluder device into a LAA using the anchoring system described above.
- an anchoring system for implanting and retrieving an occluder device into a LAA comprises an outer sheath, a pericardial catheter, an occluder device, and an anchor.
- the pericardial catheter may be advanced through the outer sheath into the LAA, wherein the pericardial catheter penetrates a wall of the LAA and enters the pericardial space creating a small hole.
- a buddy wire and/or a delivery wire are advanced through the pericardial catheter to enter the pericardial space.
- an anchor catheter, the occluder device, and the anchor are then advanced through the outer sheath using the delivery wire.
- the anchor While in a straight-coil configuration, the anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall to extend into the pericardial space.
- the anchor self-expands into a two-disc shape, wherein a first coil resides within the LAA and a second coil resides within the pericardial space.
- the outer sheath releases the occluder device into the LAA, wherein it is pinned against the LAA wall by the anchor.
- Another aspect of the present invention includes a method of implanting and retrieving an occluder device into a LAA using the anchoring system described above.
- FIGS. 1-26 represent examples of the anchoring system, anchor, and method of the present invention.
- FIG. 1 is a view of an outer sheath and pericardial catheter of an anchoring system of the present invention and method for implanting and retrieving an occluder device within a LAA.
- FIG. 2 is a view of an anchor, connector, and occluder device of the anchoring system and method of FIG. 1 .
- FIG. 3 is a view of an anchor of the anchoring system and method of claim 1 , wherein the anchor comprises anchor tines.
- FIG. 3A is an end-view of the anchor of FIG. 3 , wherein anchor tines are in a contracted first position.
- FIG. 3B is an end-view of the anchor of FIG. 3 , wherein the anchor tines are in a deployed second position.
- FIG. 4 is a view of an anchor of the anchoring system and method of FIG. 1 , wherein the anchor comprises a coil-wire.
- FIG. 4A is an end-view of the anchor of FIG. 4 , wherein a coil-wire is in a contracted first position constrained within an inner sheath.
- FIG. 4B is an end-view of the anchor of FIG. 4 , wherein the coil-wire is in a deployed second position within the pericardial space.
- FIG. 5 is a view of the anchoring system and method of FIG. 1 , wherein the anchor and the occluder device are advanced into the LAA.
- FIG. 6 is a view of the anchoring system and method of FIG. 5 , wherein the anchor is advanced through the LAA wall.
- FIG. 7 is a view of the anchoring system and method of FIG. 6 , wherein the occluder device is released from the inner sheath and positioned within the LAA.
- FIG. 8 is a view of the anchoring system and method of FIG. 7 , wherein the occluder device is retrieved inside the inner sheath and the anchor is left implanted in the LAA wall, sealing up the small hole created by the pericardial catheter.
- FIG. 9 is a view of the anchoring system and method of FIG. 8 , wherein the anchor is retracted from the LAA wall and the anchor and the occluder device are retrieved inside the inner sheath.
- FIG. 10 is a view of an outer sheath and a pericardial catheter of another aspect of an anchoring system of the present invention and method for implanting and retrieving an occluder device within a LAA.
- FIG. 11 is a view of an outer sheath, anchor catheter, and inner dilator of the anchoring system and method of FIG. 10 , wherein the inner dilator and anchor catheter penetrate the LAA wall.
- FIG. 12 is a view the anchoring system and method of FIG. 10 , wherein an occluder device and an anchor are advanced through the outer sheath and anchor catheter, respectively.
- FIG. 13 is a frontal-side view of the anchor of the anchoring system and method of FIG. 10 , wherein the anchor comprises a sheave shape with a first half, a second half, and a shaft connecting the two halves.
- FIG. 13A is a side-view of the anchor of FIG. 13 , wherein the anchor is in a contracted first position.
- FIG. 13B is a side-view of the anchor of FIG. 13 , wherein the anchor is in a deployed second position.
- FIG. 14 is a view of the anchoring system and method of FIG. 1 , wherein the second half of the anchor is deployed in the pericardial space.
- FIG. 15 is a view of the anchoring system and method of FIG. 1 , wherein the first half of the anchor is partially deployed in the occluder device.
- FIG. 16 is a view of the anchoring system and method of FIG. 1 , wherein the occluder device is released from the outer sheath and the second half of the anchor fully deployed to pin the occluder device against the LAA wall.
- FIG. 17 is a view of the anchoring system and method of FIG. 1 if problems arise after deployment of the occluder device, wherein the occluder device is retracted inside the outer sheath and the first half of the anchor is retracted inside the anchor catheter.
- FIG. 18 is a view of the anchoring system and method of FIG. 1 if problems arise after deployment of the occluder device, wherein the anchor is left implanted in the LAA wall.
- FIG. 19 is a view of an outer sheath and pericardial catheter of another aspect of an anchoring system of the present invention and method for implanting and retrieving an occluder device within a LAA.
- FIG. 20 is a view the anchoring system and method of FIG. 19 , wherein an occluder device is advanced through the outer sheath and an anchor is advanced through the anchor catheter.
- FIG. 21A is a side-view of the anchor of FIG. 20 , wherein the anchor is in a contracted first position.
- FIG. 21B is a side-view of the anchor of FIG. 20 , wherein the anchor is in a deployed second position comprising a double-coiled shape with a first half, a second half, and a shaft connecting the two halves.
- FIG. 22 is a view of the anchoring system and method of FIG. 19 , wherein the second half of the anchor is deployed in the pericardial space.
- FIG. 23 is a view of the anchoring system and method of FIG. 19 , wherein the first half of the anchor is partially deployed in the occluder device.
- FIG. 24 is a view of the anchoring system and method of FIG. 19 , wherein the occluder device is released from the outer sheath and the first half of the anchor is fully deployed to pin the occluder device against the LAA wall.
- FIG. 25 is a view of the anchoring system and method of FIG. 19 if problems arise after deployment of the occluder device, wherein the occluder device is retracted inside the outer sheath and the first half of the anchor is retracted inside the anchor catheter.
- FIG. 26 is a view of the anchoring system and method of FIG. 19 if problems arise after deployment of the occluder device, wherein the anchor is left implanted in the LAA wall.
- FIG. 1 illustrates one aspect of the present invention, an anchoring system 10 for implanting and retrieving an occluder device within a LAA.
- the anchoring system 10 may comprise a pericardial catheter 14 , wherein the pericardial catheter 14 may be a single or double-lumen pericardial catheter.
- the anchoring system 10 may further comprise an outer sheath 16 and an inner sheath 18 .
- a balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized.
- the single or double-lumen pericardial catheter 14 may be configured to fit a delivery wire 20 and/or a buddy wire 22 , also standardly used in the industry.
- a diameter of the delivery wire 20 may range between approximately 0.025-0.052 inches and a diameter of the buddy wire 22 may range between approximately 0.008 0.025 inches.
- the outer sheath 16 may be inserted into LAA 24 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude the LAA 24 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of the outer sheath 16 within the LAA 24 and allow for better imaging of the LAA 24 by an interventional cardiologist.
- the pericardial catheter 14 may be advanced through the outer sheath 16 , wherein the pericardial catheter 14 penetrates LAA wall 26 and enters pericardial space 28 .
- the pericardial catheter 14 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 .
- the pericardial catheter 14 creates a small hole 30 through the LAA wall 26 of the heart.
- the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of bleeding and fluid accumulating within the pericardial space 28 via the small hole 30 .
- the delivery wire 20 and/or the buddy wire 22 may be advanced through the pericardial catheter 14 , wherein the delivery wire 20 and/or the buddy wire 22 enter the pericardial space 28 .
- the buddy wire 22 remains inside the pericardial space 28 and is a safety feature in case of emergencies.
- the buddy wire 22 allows a interventional cardiologist to advance another catheter through the LAA wall 26 and place a plug within the small hole 30 if a malfunction is observed with the anchor 32 or the occluder device 36 .
- the pericardial catheter 14 may then be removed from the outer sheath 16 , leaving the delivery wire 20 and/or the buddy wire 22 inside the pericardial space 28 via the small hole 30 in the LAA wall 26 .
- the anchoring system 10 of the present invention further comprises an anchor 32 , an occluder device 36 , and a connector 38 .
- the anchoring system 10 of the present invention may be used with a diverse range of LAA occluder devices such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 36 is connected to the anchor 32 via the connector 38 .
- the connector 38 may be comprised of stainless steel, platinum, Nitinol, Elgiloy, or other materials standardly used in the industry.
- the connector 38 may be square, flat, rectangular, round, spherical, coiled, ovular, a combination thereof, or any other shape.
- the connector 38 may be approximately 0.5 mm-10 mm in length and approximately 0.5 mm-10 mm in width. It is intended that the connector 38 provide flexibility between the anchor 32 and the occluder device 36 . This flexibility may be achieved via an articulating joint, such as a ball-and-socket joint 44 , shown in FIG. 2 .
- the ball-and-socket joint 44 of FIG. 2 is illustrated for example purposes only. It is not intended that the connector 38 of the present invention be limited to a ball-and-socket joint 44 . Rather, it is intended that other articulating connectors standardly used in the industry may also be utilized, such as hinge joints, pivot joints, ellipsoid joints, gliding joints, saddle joints, and others. It is important that the connector 38 provide flexibility between the occluder device 36 and the anchor 32 to allow for multiple insertion sites within the LAA 24 , thus, ensuring the occluder device 36 is properly positioned within the LAA 24 once deployed.
- the connector 38 may allow an interventional cardiologist via a cable (not shown) to conveniently attach the occluder device 36 to the anchor 32 , release the occluder device 36 from the anchor 32 , and reattach the occluder device 36 to the anchor 32 without damaging the occluder device 36 .
- the anchor 32 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape.
- the length of the anchor 32 may be approximately 1-10 mm, wherein the width of the anchor 32 may be approximately 1-20 mm.
- the anchor 32 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 32 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 may comprise a plurality of self-expanding anchor tines 39 , wherein the plurality may comprise 2-10 tines.
- the anchor tines 39 may be approximately 5-20 mm in length and approximately 0.01-1.5 mm in width.
- the anchor tines 39 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor tines 39 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor tines 39 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the anchor tines 39 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 of the present invention may comprise a self-expanding coil-wire 40 instead of the anchor tines 39 as illustrated in FIG. 4 .
- the coil-wire 40 may be approximately 5-25 mm in length and 0.01-1.5 mm in width.
- the coil-wire 40 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the coil-wire 40 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the coil-wire 40 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the coil-wire 40 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 may have a contracted first position ( FIGS. 3A, 4A ) and a deployed second position ( FIGS. 3B, 4B ).
- the anchor tines 39 When the anchor tines 39 are utilized, the anchor tines 39 may expand outwards a distance of approximately 2-20 mm in diameter in the deployed second position ( FIG. 3B ).
- the coil-wire 40 when the coil-wire 40 is utilized, the coil-wire may have a circular diameter of 0.01-1.5 mm in the contracted first position ( FIG. 4A ), and may have a circular diameter of approximately 5-20 mm in the deployed second position ( FIG. 4B ).
- the diameter of the contracted first position and deployed second position of the coil-wire 40 may have any shape compatible with the LAA 24 .
- the inner sheath 18 is advanced up to and adjacent the LAA wall 26 .
- the anchor 32 , the connector 38 , and the occluder device 36 are next advanced through the inner sheath 18 using the delivery wire 20 , wherein the anchor 32 resides adjacent the small hole 30 in the LAA wall 26 .
- the anchor 32 , the connector 38 , and the occluder device 36 are further advanced through the inner sheath 18 using the delivery wire 20 , wherein the anchor 32 penetrates the LAA wall 26 via the small hole 30 and extends into the pericardial space 28 .
- the anchor 32 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 .
- the anchor 32 self-expands from the contracted first position ( FIGS. 3A, 4A ) to the deployed second position ( FIGS. 3B, 4B ).
- the inner sheath 18 is retracted inside the outer sheath 16 after the anchor 32 has been implanted in the LAA wall 26 .
- the expanded anchor 32 in the deployed second position covers a large surface area and therefore retains the occluder device 36 in an implanted position within the LAA 24 .
- the anchoring system 10 of the present invention lowers the risk of embolization.
- FIGS. 8-9 illustrate the anchoring system 10 of the present invention if problems arise after deployment of the occluder device 36 . For instance, it may be determined that the occluder device 36 is not placed in an optimal location of the LAA 24 after deployment to achieve maximum occlusion.
- the anchoring system 10 of the present invention offers two solutions to overcome these problems.
- the first solution is illustrated in FIG. 8 , wherein an interventional cardiologist may use a cable (not shown) to detach 42 the occluder device 36 from the anchor 32 via connector 38 .
- the occluder device 36 is then retrieved inside the inner sheath 18 via the cable.
- the anchor 32 is expendable and may be left implanted in the LAA wall 26 where it causes no harm to the patient.
- a new anchor 32 is then connected to the occluder device 36 via the connector 38 , and the anchoring steps repeated until optimal placement of the occluder device 36 within the LAA 24 is achieved.
- the second solution is illustrated in FIG. 9 , wherein the occluder device 36 is retrieved inside the inner sheath 18 via a cable (not shown).
- the inner sheath 18 is then advanced to envelope the anchor 32 and press up against the LAA wall 26 . While the inner sheath 18 is pressed up against the LAA wall 26 , the anchor 32 is pulled back through the LAA wall 26 , into the LAA 24 , and retrieved 46 inside the inner sheath 18 via the cable.
- the anchor 32 is designed to retract from the deployed second position ( FIGS. 3B, 4B ) into the contracted first position ( FIGS. 3A, 4A ) without tearing or ripping the LAA wall 26 as the anchor 32 is retrieved inside the inner sheath 18 .
- the anchoring system 10 of the present invention allows an interventional cardiologist to quickly and cost-effectively implant the occluder device 36 into the LAA 24 using anchor 32 , safely retrieve the occluder device 36 and anchor 32 if initial placement was improper or if complications arise, and then reuse and re-implant the occluder device 36 and anchor 32 in an optimal location of the LAA 24 .
- the delivery wire 20 and buddy wire 22 are removed from the LAA via the outer 16 sheath.
- the outer sheath 16 may be subsequently removed from the LAA 24 via the left atrium proper of the heart.
- an anchor 32 is provided for anchoring an occluder device 36 within the LAA 24 .
- the anchor 32 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape.
- the length of the anchor 32 may be approximately 1-10 mm, wherein the width of the anchor 32 may be approximately 1-20 mm.
- the anchor 32 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 32 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 is further configured to connect to an occluder device 36 via a connector 38 .
- the connector 38 may be comprised of stainless steel, platinum, Nitinol, Elgiloy, or other materials standardly used in the industry.
- the connector 38 may be square, flat, rectangular, round, spherical, coiled, ovular, a combination thereof, or any other shape.
- the connector 38 may be approximately 0.5 mm-10 mm in length and approximately 0.5 mm-10 mm in width. It is intended that the connector 38 provide flexibility between the anchor 32 and the occluder device 36 . This flexibility may be achieved via an articulating joint, such as a ball-and-socket joint 44 , shown in FIG. 2 .
- the ball-and-socket joint 44 of FIG. 2 is illustrated for example purposes only. It is not intended that the connector 38 of the present invention be limited to a ball-and-socket joint 44 . Rather, it is intended that other articulating connectors standardly used in the industry may also be utilized, such as hinge joints, pivot joints, ellipsoid joints, gliding joints, saddle joints, and others. It is important that the connector 38 provide flexibility between the occluder device 36 and the anchor 32 to allow for multiple insertion sites within the LAA 24 , thus, ensuring the occluder device 36 is properly positioned within the LAA 24 once deployed.
- the connector 38 may allow an interventional cardiologist via a cable (not shown) to conveniently attach the occluder device 36 to the anchor 32 , release the occluder device 36 from the anchor 32 , and reattach the occluder device 36 to the anchor 32 without damaging the occluder device 36 .
- the anchor 32 may comprise a plurality of self-expanding anchor tines 39 , wherein the plurality may comprise 2-10 tines.
- the anchor tines 39 may be approximately 5-20 mm in length and approximately 0.01-1.5 mm in width.
- the anchor tines 39 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor tines 39 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor tines 39 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the anchor tines 39 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 of the present invention may comprise a self-expanding coil-wire 40 instead of the anchor tines 39 as illustrated in FIG. 4 .
- the coil-wire 40 may be approximately 5-25 mm in length and 0.01-1.5 mm in width.
- the coil-wire 40 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the coil-wire 40 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the coil-wire 40 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the coil-wire 40 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 may have a contracted first position ( FIGS. 3A, 4A ) and a deployed second position ( FIGS. 3B, 4B ).
- the anchor tines 39 When the anchor tines 39 are utilized, the anchor tines 39 may expand outwards a distance of approximately 2-20 mm in diameter in the deployed second position ( FIG. 3B ).
- the coil-wire 40 when the coil-wire 40 is utilized, the coil-wire may have a circular diameter of 0.01-1.5 mm in the contracted first position ( FIG. 4A ), and may have a circular diameter of approximately 5-20 mm in the deployed second position ( FIG. 4B ).
- the diameter of the contracted first position and deployed second position of the coil-wire 40 may have any shape compatible with the LAA 24 .
- the anchor 32 is configured to penetrate the LAA wall 26 via a pre-made small hole 30 through the LAA wall. Specifically, the anchor 32 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 .
- the anchor 32 extends into the pericardial space 28 , wherein the anchor 32 self-expands from the contracted first position ( FIGS. 3A, 4A ) to the deployed second position ( FIGS. 3B, 4B ).
- the expanded anchor 32 in the deployed second position covers a large surface area and therefore retains the occluder device 36 in an implanted position within the LAA 24 .
- the anchor 32 of the present invention lowers the risk of embolization.
- FIG. 1 a method of implanting and retrieving an occluder device within a LAA is illustrated in FIG. 1 .
- the method of the present invention comprises providing an anchoring system 10 .
- the anchoring system 10 comprises a pericardial catheter 14 , wherein the pericardial catheter 14 may be a single or double-lumen pericardial catheter.
- the anchoring system 10 may further comprise an outer sheath 16 and an inner sheath 18 .
- a balloon-occlusion catheter may also be utilized in the present invention. However, it is intended that other catheters standard in the industry may also be utilized.
- the pericardial catheter 14 may be configured to fit a delivery wire 20 and/or a buddy wire 22 , also standardly used in the industry.
- a diameter of the delivery wire 20 may range between approximately 0.025-0.052 inches and a diameter of the buddy wire 22 may range between approximately 0.008-0.025 inches.
- the method of the present invention comprises inserting the outer sheath 16 into LAA 24 via the left atrium proper of the heart. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude the LAA 24 from the left atrium proper.
- the pericardial catheter 14 may be advanced through the outer sheath 16 , wherein the pericardial catheter 14 penetrates LAA wall 26 and enters pericardial space 28 . Specifically, the pericardial catheter 14 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 . Thus, the pericardial catheter 14 creates a small hole 30 through the LAA wall 26 of the heart.
- the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within the pericardial space 28 via the small hole 30 .
- the delivery wire 20 and the buddy wire 22 may be advanced through the pericardial catheter 14 , wherein the delivery wire 20 and the buddy wire 22 enter the pericardial space 28 .
- the buddy wire 22 remains inside the pericardial space 28 and is a safety feature in case of emergencies.
- the buddy wire 22 allows an interventional cardiologist to advance another catheter through the LAA wall 26 and place a plug within the small hole 30 if a malfunction is observed with the anchor 32 or the occluder device 36 .
- the pericardial catheter 14 may then be removed from the outer sheath 16 , leaving the delivery wire 20 and the buddy wire 22 inside the pericardial space 28 via the small hole 30 in the LAA wall 26 .
- the method of the present invention further comprises providing an anchor 32 , an occluder device 36 , and a connector 38 .
- the method of the present invention may be used with a diverse range of LAA occluder devices such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the method of the present invention comprises connecting the occluder device 36 to the anchor 32 via the connector 38 .
- the connector 38 may be comprised of stainless steel, platinum, Nitinol, Elgiloy, or other materials standardly used in the industry.
- the connector 38 may be square, flat, rectangular, round, spherical, coiled, ovular, a combination thereof, or any other shape.
- the connector 38 may be approximately 0.5 mm-10 mm in length and approximately 0.5 mm-10 mm in width. It is intended that the connector 38 provide flexibility between the anchor 32 and the occluder device 36 . This flexibility may be achieved via an articulating joint, such as a ball-and-socket joint 44 , shown in FIG. 2 .
- the ball-and-socket joint 44 of FIG. 2 is illustrated for example purposes only. It is not intended that the connector 38 of the present invention be limited to a ball-and-socket joint 44 . Rather, it is intended that other articulating connectors standardly used in the industry may also be utilized, such as hinge joints, pivot joints, ellipsoid joints, gliding joints, saddle joints, and others. It is important that the connector 38 provide flexibility between the occluder device 36 and the anchor 32 to allow for multiple insertion sites within the LAA 24 , thus, ensuring the occluder device 36 is properly positioned within the LAA 24 once deployed.
- the connector 38 may allow an interventional cardiologist via a cable (not shown) to conveniently attach the occluder device 36 to the anchor 32 , release the occluder device 36 from the anchor 32 , and reattach the occluder device 36 to the anchor 32 without damaging the occluder device 36 .
- the anchor 32 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape.
- the length of the anchor 32 may be approximately 1-10 mm, wherein the width of the anchor 32 may be approximately 1-20 mm.
- the anchor 32 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 32 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 may comprise a plurality of self-expanding anchor tines 39 , wherein the plurality may comprise 2-10 tines.
- the anchor tines 39 may be approximately 5-20 mm in length and approximately 0.01-1.5 mm in width.
- the anchor tines 39 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor tines 39 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor tines 39 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the anchor tines 39 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 of the present invention may comprise a self-expanding coil-wire 40 instead of the anchor tines 39 as illustrated in FIG. 4 .
- the coil-wire 40 may be approximately 5-25 mm in length and 0.01-1.5 mm in width.
- the coil-wire 40 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the coil-wire 40 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the coil-wire 40 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the coil-wire 40 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 32 may have a contracted first position ( FIGS. 3A, 4A ) and a deployed second position ( FIGS. 3B, 4B ).
- the anchor tines 39 When the anchor tines 39 are utilized, the anchor tines 39 may expand outwards a distance of approximately 2-20 mm in diameter in the deployed second position ( FIG. 3B ).
- the coil-wire 40 when the coil-wire 40 is utilized, the coil-wire may have a circular diameter of 0.01-1.5 mm in the contracted first position ( FIG. 4A ), and may have a circular diameter of approximately 5-20 mm in the deployed second position ( FIG. 4B ).
- the diameter of the contracted first position and deployed second position of the coil-wire 40 may have any shape compatible with the LAA 24 .
- the method of the present invention further comprises advancing the inner sheath 18 up to and adjacent the LAA wall 26 .
- the anchor 32 , the connector 38 , and the occluder device 36 are next advanced through the inner sheath 18 using the delivery wire 20 , wherein the anchor 32 resides adjacent the small hole 30 in the LAA wall 26 .
- the method of the present invention comprises further advancing the anchor 32 , the anchor tines 39 , the connector 38 , and the occluder device 36 through the inner sheath 18 using the delivery wire 20 , wherein the anchor 32 penetrates the LAA wall 26 via the small hole 30 and extends into the pericardial space 28 .
- the anchor 32 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 .
- the anchor 32 self-expands from the contracted first position ( FIGS. 3A, 4A ) to the deployed second position ( FIGS. 3B, 4B ).
- the method of the present invention further comprises retracting the inner sheath 18 inside the outer sheath 16 after the anchor 32 has been implanted in the LAA wall 26 .
- the expanded anchor 32 in the deployed second position covers a large surface area and therefore retains the occluder device 36 in an implanted position within the LAA 24 .
- the anchoring system 10 of the present invention lowers the risk of embolization.
- FIGS. 8-9 illustrate the method of the present invention, further comprising making a determination whether a problem has arisen after deployment of the occluder device 36 . For example, it may be determined that the occluder device 36 is not placed in an optimal location of the LAA 24 after deployment to achieve maximum occlusion.
- the method of the present invention offers two alternative solutions to overcome these problems.
- the first solution is illustrated in FIG. 8 , wherein an interventional cardiologist may use a cable (not shown) to detach 42 the occluder device 36 from the anchor 32 via connector 38 .
- the occluder device 36 is then retrieved inside the inner sheath 18 via the cable.
- the anchor 32 is expendable and may be left implanted in the LAA wall 26 where it causes no harm to the patient.
- a new anchor 32 is then connected to the occluder device 36 via the connector 38 , and the anchoring steps repeated until optimal placement of the occluder device 36 within the LAA 24 is achieved.
- the second solution is illustrated in FIG. 9 , wherein the occluder device 36 is retrieved inside the inner sheath 18 via a cable (not shown).
- the inner sheath 18 is then advanced to envelope the anchor 32 and press up against the LAA wall 26 . While the inner sheath 18 is pressed up against the LAA wall 26 , the anchor 32 is pulled back through the LAA wall 26 , into the LAA 24 , and retrieved 46 inside the inner sheath 18 via the cable.
- the anchor 32 is designed to retract from the deployed second position ( FIGS. 3B, 4B ) into the contracted first position ( FIGS. 3A, 4A ) without tearing or ripping the LAA wall 26 as the anchor 32 is retrieved inside the inner sheath 18 .
- the method of the present invention allows an interventional cardiologist to quickly and cost-effectively implant the occluder device 36 into the LAA 24 using anchor 32 , safely retrieve the occluder device 36 and anchor 32 if initial placement was improper or if complications arise, and then reuse and re-implant the same occluder device 36 and anchor 32 in an optimal location of the LAA 24 .
- the delivery wire 20 and buddy wire 22 are removed from the LAA via the outer sheath 16 .
- the outer sheath 16 may be subsequently removed from the LAA 24 via the left atrium proper of the heart.
- FIG. 10 illustrates a further aspect of the present invention, an anchoring system 50 for implanting and retrieving an occluder device within a LAA.
- the anchoring system 50 may comprise a pericardial catheter 54 , wherein the pericardial catheter 54 may be a single or double-lumen pericardial catheter.
- the anchoring system 50 may further comprise an outer sheath 56 .
- a balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized.
- the pericardial catheter 54 may be configured to fit a delivery wire 60 and/or a buddy wire 62 , also standardly used in the industry.
- a diameter of the delivery wire 60 may range between approximately 0.025-0.052 inches and a diameter of the buddy wire 62 may range between approximately 0.008-0.025 inches.
- the outer sheath 56 may be inserted into LAA 64 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude the LAA 64 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of the outer sheath 56 within the LAA 64 and allow for better imaging of the LAA 64 by an interventional cardiologist.
- the pericardial catheter 54 may be advanced through the outer sheath 56 to the LAA wall 66 .
- the buddy wire 62 is next advanced through the pericardial catheter 54 and the adjacent LAA wall 66 , wherein the buddy wire 62 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 to extend into the pericardial space 68 .
- the pericardial catheter 54 is next advanced over the buddy wire 62 and through the LAA wall 66 , penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 to extend into the pericardial space 68 .
- the pericardial catheter 54 creates a small hole 70 through the LAA wall 66 of the heart.
- the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within the pericardial space 68 via the small hole 70 .
- the delivery wire 60 may then be advanced through the pericardial catheter 54 , wherein the delivery wire 60 enters the pericardial space 68 .
- the pericardial catheter 54 may then be removed from the outer sheath 56 , leaving the delivery wire 60 and the buddy wire 62 inside the pericardial space 68 via the small hole 70 in the LAA wall 66 .
- the anchoring system 50 of the present invention further comprises an anchor catheter 58 and an inner dilator 86 , wherein the inner dilator 86 includes a pointed distal end 88 .
- the inner dilator 86 may be configured to encompass the delivery wire 60 , wherein the delivery wire 60 may traverse through an inner lumen of the inner dilator 86 .
- the anchor catheter 58 and the inner dilator 86 may be advanced through the outer sheath 56 to the LAA wall 66 adjacent the small hole 70 .
- the delivery wire 60 may traverse through the anchor catheter 52 and the inner dilator 86 .
- the buddy wire 62 may reside outside the anchor catheter 58 and yet inside the outer sheath 56 .
- the inner dilator 86 and the anchor catheter 52 may be further advanced through the small hole 70 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 .
- the pointed distal end 88 of the inner dilator 86 along with a distal end of the anchor catheter 52 , extends into the pericardial space 68 .
- the inner dilator 86 may be subsequently removed from the anchor catheter 58 , wherein the distal end of the anchor catheter 58 remains extending into the pericardial space 68 .
- the anchoring system 50 of the present invention further comprises an occluder device 80 and an occluder cable 84 .
- the anchoring system 50 of the present invention may be used with a diverse range of LAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices 80 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 80 may have a distal end with a hole approximately 1-5 mm in diameter.
- the occluder cable 84 may be a hollow coaxial cable standardly used in the industry.
- the occluder cable 84 may be attached to the occluder device 80 , wherein the occluder cable 84 may be used for deploying and retrieving the occluder device 80 within the LAA 64 .
- the occluder device 80 and the occluder cable 84 may encompass the anchor catheter 58 , wherein the anchor catheter 58 may traverse through an inner lumen of the occluder device 80 and an inner lumen of the occluder cable 84 .
- the occluder device 80 may reside between the anchor catheter 58 and the outer sheath 56 .
- the anchoring catheter 58 may comprise an anchor 72 and an anchor cable 82 .
- the anchor cable 82 may be attached to the anchor 72 , wherein the anchor cable 82 may be used for deploying the anchor 72 within the LAA wall 66 .
- the anchor cable 82 may be a hollow coaxial cable standardly used in the industry.
- the anchor cable 82 and anchor 72 may encompass the delivery wire 60 , wherein the delivery wire 60 may traverse through an inner lumen of the anchor 72 and an inner lumen of the anchor cable 82 .
- the delivery wire 60 may be used to navigate the anchoring system 50 through the LAA 64 .
- the anchor 72 and anchor cable 82 may be advanced through the anchor catheter 58 into the pericardial space 68 without using the delivery wire 60 .
- the buddy wire 62 may remain inside the pericardial space 68 and is a safety feature in case of emergencies.
- the buddy wire 62 allows an interventional cardiologist to advance another catheter through the LAA wall 66 and place a plug within the small hole 70 if a malfunction is observed with the anchor 72 or the occluder device 80 .
- the anchor 72 may be shaped like a sheave, comprising a first half 74 , a second half 76 , and a shaft 78 connecting the first half 74 to the second half 76 , although it is contemplated that other anchor shapes may also be utilized in the present invention.
- the anchor 72 may be comprised of wire, wherein the first half 74 and second half 76 of the anchor 72 comprise wire mesh, further wherein the shaft 78 may comprise a single wire connecting the first half 75 wire mesh and the second half 76 wire mesh.
- the anchor 72 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape, and may be comprised of single or multiple wires.
- the anchor 72 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor 72 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 72 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 72 may have a lumen wherein the delivery wire 60 traverses therein, alternatively, the anchor 72 may not have a lumen.
- the anchor 72 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor 72 may have a contracted first position ( FIG. 13A ) and a deployed second position ( FIG. 13B ).
- the contracted first position ( FIG. 13A ) the first half 74 , second half 76 , and shaft 78 of the anchor 72 have a diameter of approximately 1-5 mm and a length of approximately 5-55 mm.
- the deployed second position ( FIG. 13B ) the first half 74 and second half 76 of the anchor 72 may expand outwards a distance of approximately 5-25 mm in diameter, wherein the shaft 78 remains approximately 1-5 mm in diameter.
- the anchor 72 may self-expand from the contracted first position ( FIG. 13A ) to the deployed second position ( FIG. 13B ).
- the anchor 72 in the contracted first position may be advanced through the anchor catheter 58 using the anchor cable 82 and the delivery wire 60 , wherein the anchor 72 extends into the pericardial space 68 .
- the anchor catheter 58 may then be retracted, allowing the second half 76 of the anchor 72 to self-expand from the contracted first position to the deployed second position within the pericardial space 68 . While the second half 76 of the anchor 72 is in the deployed second position, the shaft 78 and the first half 74 of the anchor 72 remain temporarily inside the anchor catheter 58 .
- the anchor catheter 58 may be further retracted, allowing the first half 74 of the anchor 72 to self-expand from the contracted first position to a partially deployed second position within the occluder device 80 , wherein the occluder device 80 remains inside the outer sheath 56 .
- the shaft 78 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 .
- the second half 76 of the anchor 72 remains in the deployed second position within the pericardial space 68 , wherein the first half 74 of the anchor 72 is in the partially deployed second position within the occluder device 80 .
- the anchor 72 and occluder device 80 may be integral, wherein the occluder device 80 may be a coil occluder device.
- the integral anchor 72 and occluder device 80 may be advanced together through the anchor catheter 58 , wherein the anchor 72 is implanted in the LAA wall 66 using the system 50 of the present invention described above.
- the outer sheath 56 may be retracted to allow the occluder device 80 to expand inside the LAA 64 . Moreover, retracting the outer sheath 56 allows the first half 74 of the anchor 72 to fully expand into the deployed second position within the occluder device 80 .
- the shaft 78 of the anchor 72 may extend through the hole in the distal end of the occluder device 80 , wherein the distal end of the occluder device 80 pinches down on the shaft 78 .
- the first half of the anchor 74 in the deployed second position may pin the occluder device 80 against the LAA wall 66 , wherein the anchor 72 effectively moors the occluder device 80 inside the LAA 64 .
- the expanded anchor 72 in the deployed second position covers a large surface area and therefore retains the occluder device 80 in an implanted position within the LAA 64 .
- the anchoring system 50 of the present invention lowers the risk of embolization.
- the anchor cable 82 remains attached to the anchor 72 and the occluder cable 84 remains attached to the occluder device 80 in case problems arise after deployment of the occluder device 80 .
- the occluder cable 84 may be detached from the occluder device 80 and removed from the LAA 64 .
- the anchor cable 82 may be detached from the anchor 72 and removed from the LAA 64 .
- the buddy wire 62 and delivery wire 60 may also be withdrawn from the LAA 64 , leaving the occluder device 80 anchored securely in the LAA 64 by the anchoring system 50 of the present invention.
- FIG. 17 illustrates the anchoring system 50 of the present invention if problems arise after deployment of the occluder device 80 .
- the occluder device 80 may be determined that the occluder device 80 is not placed in an optimal location of the LAA 64 after deployment to achieve maximum occlusion.
- the outer sheath 56 may be advanced over the occluder device 80 to the LAA wall 66 , wherein the occluder device 80 is retracted inside the outer sheath 56 using the occluder cable 82 .
- the anchor catheter 58 may then be advanced to the LAA wall 66 , wherein the first half 74 of the anchor 72 is retracted inside the anchor catheter 58 using the anchor cable 82 .
- the first half 74 of the anchor 72 retracts from the deployed second position to the contracted first position to fit inside the anchor catheter 58 .
- the outer sheath 56 containing the occluder device 80 may then be removed from the LAA 64 , or the occluder device 80 may be re-deployed in a more optimal location of the LAA 64 .
- the anchor catheter 58 may be retrieved thereafter, allowing the first half 74 of the anchor 72 to expand from the contracted first position to the deployed second position within the LAA 64 .
- the deployed anchor 72 remains inside the LAA 64 and allows for occlusion of the small hole 70 that was created by the pericardial catheter 54 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 .
- the anchor 72 may be released from the anchor cable 82 and deployed alone within the LAA wall 66 to plug the small hole 70 and prevent fluids from entering the pericardial space 68 .
- the delivery wire 60 and buddy wire 62 may be subsequently removed from the LAA 64 . This allows for a new anchor 72 to be placed within the LAA wall 66 using the anchoring system 50 cited above for achieving optimal placement of the occluder device 80 within the LAA 64 .
- the anchoring system 50 of the present invention allows an interventional cardiologist to quickly and cost-effectively implant the occluder device 80 into the LAA 64 using anchor 72 , safely retrieve or re-deploy the occluder device 80 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of the LAA 24 .
- the delivery wire 60 and buddy wire 62 may be removed from the LAA 64 .
- an anchor 72 for anchoring an occluder device 80 within a LAA 64 .
- the anchor 72 may be shaped like a sheave, comprising a first half 74 , a second half 76 , and a shaft 78 connecting the first half 74 to the second half 76 , although it is contemplated that other anchor shapes may also be utilized in the present invention.
- the anchor 72 may be comprised of wire, wherein the first half 74 and second half 76 of the anchor 72 comprise wire mesh, further wherein the shaft 78 may comprise a single wire connecting the first half 75 wire mesh and the second half 76 wire mesh.
- the anchor 72 may further be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape, and may be comprised of single or multiple wires.
- the anchor 72 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor 72 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 72 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 72 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor 72 may have a contracted first position ( FIG. 13A ) and a deployed second position ( FIG. 13B ).
- the contracted first position ( FIG. 13A ) the first half 74 , second half 76 , and shaft 78 of the anchor 72 have a diameter of approximately 1-5 mm and a length of approximately 5-55 mm.
- the deployed second position ( FIG. 13B ) the first half 74 and second half 76 of the anchor 72 may expand outwards a distance of approximately 5-25 mm in diameter, wherein the shaft 78 remains approximately 1-5 mm in diameter.
- the anchor 72 may self-expand from the contracted first position ( FIG. 13A ) to the deployed second position ( FIG. 13B ).
- the anchor 72 of the present invention may be used with a diverse range of LAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- LAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices 80 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 80 may have a distal end with a hole approximately 1-5 mm in diameter.
- the anchor 72 in the contracted first position may be advanced through an anchor catheter 58 using an anchor cable 82 and a delivery wire 60 , wherein the anchor 72 extends into pericardial space 68 .
- the anchor catheter 58 may then be retracted, allowing the second half 76 of the anchor 72 to self-expand from the contracted first position to the deployed second position within the pericardial space 68 . While the second half 76 of the anchor 72 is in the deployed second position, the shaft 72 and the first half 74 of the anchor 72 remain temporarily inside the anchor catheter 58 .
- the anchor catheter 58 may be further retracted, allowing the first half 74 of the anchor 72 to self-expand from the contracted first position to a partially deployed second position within the occluder device 80 , wherein the occluder device 80 remains inside the outer sheath 56 .
- the shaft 78 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 .
- the second half 76 of the anchor 72 remains in the deployed second position within the pericardial space 68 , wherein the first half 74 of the anchor 72 is in the partially deployed second position within the occluder device 80 .
- the anchor 72 and occluder device 80 may be integral, wherein the occluder device 80 may be a coil occluder device.
- the integral anchor 72 and occluder device 80 may be advanced together through the anchor catheter 58 , wherein the anchor 72 is implanted in the LAA wall 26 using the system 50 of the present invention described above.
- the outer sheath 56 may be retracted to allow the occluder device 80 to expand inside the LAA 64 . Moreover, retracting the outer sheath 56 allows the first half 74 of the anchor 72 to fully expand into the deployed second position within the occluder device 80 .
- the shaft 78 of the anchor 72 may extend through the hole in the distal end of the occluder device 80 , wherein the distal end of the occluder device 80 pinches down on the shaft 78 .
- the first half of the anchor 74 in the deployed second position may pin the occluder device 80 against the LAA wall 66 , wherein the anchor 72 effectively moors the occluder device 80 inside the LAA 64 .
- the expanded anchor 72 in the deployed second position covers a large surface area and therefore retains the occluder device 80 in an implanted position within the LAA 64 .
- the anchoring system 50 of the present invention lowers the risk of embolization.
- the anchor cable 82 remains attached to the anchor 72 and an occluder cable 84 remains attached to the occluder device 80 in case problems arise after deployment of the occluder device 80 .
- the occluder cable 84 may be detached from the occluder device 80 and removed from the LAA 64 .
- the anchor cable 82 may be detached from the anchor 72 and removed from the LAA 64 .
- the delivery wire 60 and/or a buddy wire 62 may also be withdrawn from the LAA 64 , leaving the occluder device 80 anchored securely in the LAA 64 by the anchor 72 of the present invention.
- FIG. 10 a method of implanting and retrieving an occluder device within a LAA is illustrated in FIG. 10 .
- the method of the present invention comprises providing an anchoring system 50 .
- the anchoring system 50 may comprise a pericardial catheter 54 , wherein the pericardial catheter 54 may be a single or double-lumen pericardial catheter.
- the anchoring system 50 may further comprise an outer sheath 56 .
- a balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized.
- the pericardial catheter 54 may be configured to fit a delivery wire 60 and/or a buddy wire 62 , also standardly used in the industry.
- a diameter of the delivery wire 60 may range between approximately 0.025-0.052 inches and a diameter of the buddy wire 62 may range between approximately 0.008-0.025 inches.
- the method of the present invention further comprises inserting the outer sheath 56 into the LAA 64 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure.
- the balloon occlusion may be expanded to occlude the LAA 64 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of the outer sheath 56 within the LAA 64 and allow for better imaging of the LAA 64 by an interventional cardiologist.
- the pericardial catheter 54 may be advanced through the outer sheath 56 to the LAA wall 66 .
- the buddy wire 62 is next advanced through the pericardial catheter 54 and the adjacent LAA wall 66 , wherein the buddy wire 62 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 26 to extend into the pericardial space 68 .
- the pericardial catheter 54 is advanced over the buddy wire 62 and through the LAA wall 66 , penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 to extend into the pericardial space 68 .
- the pericardial catheter 54 creates a small hole 70 through the LAA wall 66 of the heart.
- the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within the pericardial space 68 via the small hole 70 .
- the delivery wire 60 may then be advanced through the pericardial catheter 54 , wherein the delivery wire 60 enters the pericardial space 68 .
- the pericardial catheter 54 may then be removed from the outer sheath 56 , leaving the delivery wire 60 and the buddy wire 62 inside the pericardial space 68 via the small hole 70 in the LAA wall 66 .
- the method of the present invention further comprises providing an anchor catheter 58 and an inner dilator 86 , wherein the inner dilator 86 includes a pointed distal end 88 .
- the inner dilator 86 may be configured to encompass the delivery wire 60 , wherein the delivery wire 60 may traverse through an inner lumen of the inner dilator 86 .
- the anchor catheter 58 and the inner dilator 86 may be advanced through the outer sheath 56 to the LAA wall 66 adjacent the small hole 70 .
- the delivery wire 60 may traverse through the anchor catheter 52 and the inner dilator 86 .
- the buddy wire 62 may reside outside the anchor catheter 58 and yet inside the outer sheath 56 .
- the inner dilator 86 and the anchor catheter 52 may be further advanced through the small hole 70 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 .
- the pointed distal end 88 of the inner dilator 86 along with a distal end of the anchor catheter 52 , extends into the pericardial space 68 .
- the inner dilator 86 may be subsequently removed from the anchor catheter 58 , wherein the distal end of the anchor catheter 58 remains extending into the pericardial space 68 .
- the method of the present invention further comprises providing an occluder device 80 and an occluder cable 84 .
- the method of the present invention may be used with a diverse range of LAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices 80 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 80 may have a distal end with a hole approximately 1-5 mm in diameter.
- the occluder cable 84 may be a hollow coaxial cable standardly used in the industry.
- the occluder cable 84 may be attached to the occluder device 80 , wherein the occluder cable 84 may be used for deploying and retrieving the occluder device 80 within the LAA 64 .
- the occluder device 80 and the occluder cable 84 may encompass the anchor catheter 58 , wherein the anchor catheter 58 may traverse through an inner lumen of the occluder device 80 and an inner lumen of the occluder cable 84 .
- the occluder device 80 may reside between the anchor catheter 58 and the outer sheath 56 .
- the method of the present invention further comprises providing an anchor 72 and an anchor cable 82 , wherein the anchor 72 and anchor cable 82 are inserted in the anchor catheter 58 .
- the anchor cable 82 may be attached to the anchor 72 , wherein the anchor cable 82 may be used for deploying the anchor 72 within the LAA wall 66 .
- the anchor cable 82 may be a hollow coaxial cable standardly used in the industry.
- the anchor cable 82 and anchor 72 may encompass the delivery wire 60 , wherein the delivery wire 60 may traverse through an inner lumen of the anchor 72 and an inner lumen of the anchor cable 82 .
- the delivery wire 60 may be used to navigate the anchoring system 50 through the LAA 64 .
- the anchor 72 and anchor cable 82 may be advanced through the anchor catheter 58 into the pericardial space 68 without using the delivery wire 60 .
- the buddy wire 62 may remain inside the pericardial space 68 and is a safety feature in case of emergencies.
- the buddy wire 62 allows an interventional cardiologist to advance another catheter through the LAA wall 66 and place a plug within the small hole 70 if a malfunction is observed with the anchor 72 or the occluder device 80 .
- the anchor 72 may be shaped like a sheave, comprising a first half 74 , a second half 76 , and a shaft 78 connecting the first half 74 to the second half 76 , although it is contemplated that other anchor shapes may also be utilized in the present invention.
- the anchor 72 may be comprised of wire, wherein the first half 74 and second half 76 of the anchor 72 comprise wire mesh, further wherein the shaft 78 may comprise a single wire connecting the first half 75 wire mesh and the second half 76 wire mesh.
- the anchor 72 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape, and may be comprised of single or multiple wires.
- the anchor 72 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor 72 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 72 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 72 may have a lumen wherein the delivery wire 60 traverses therein, alternatively, the anchor 72 may not have a lumen.
- the anchor 72 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor 72 may have a contracted first position ( FIG. 13A ) and a deployed second position ( FIG. 13B ).
- the contracted first position ( FIG. 13A ) the first half 74 , second half 76 , and shaft 78 of the anchor 72 have a diameter of approximately 1-5 mm and a length of approximately 5-55 mm.
- the deployed second position ( FIG. 13B ) the first half 74 and second half 76 of the anchor 72 may expand outwards a distance of approximately 5-25 mm in diameter, wherein the shaft 78 remains approximately 1-5 mm in diameter.
- the anchor 72 may self-expand from the contracted first position ( FIG. 13A ) to the deployed second position ( FIG. 13B ).
- the method of the present invention comprises advancing the anchor 72 in the contracted first position ( FIG. 13A ) through the anchor catheter 58 using the anchor cable 82 and the delivery wire 60 , wherein the anchor 72 extends into the pericardial space 68 .
- the anchor catheter 58 may then be retracted, allowing the second half 76 of the anchor 72 to self-expand from the contracted first position to the deployed second position within the pericardial space 68 . While the second half 76 of the anchor 72 is in the deployed second position, the shaft 78 and the first half 74 of the anchor 72 remain temporarily inside the anchor catheter 58 .
- the method of the present invention further comprises retracting the anchor catheter 58 , allowing the first half 74 of the anchor 72 to self-expand from the contracted first position to a partially deployed second position within the occluder device 80 , wherein the occluder device 80 remains inside the outer sheath 56 .
- the shaft 78 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 .
- the second half 76 of the anchor 72 remains in the deployed second position within the pericardial space 68 , wherein the first half 74 of the anchor 72 is in the partially deployed second position within the occluder device 80 .
- the anchor 72 and occluder device 80 may be integral, wherein the occluder device 80 may be a coil occluder device.
- the integral anchor 72 and occluder device 80 may be advanced together through the anchor catheter 58 , wherein the anchor 72 is implanted in the LAA wall 66 using the system 50 of the present invention described above.
- the method of the present invention comprises retracting the outer sheath 56 to allow the occluder device 80 to expand inside the LAA 64 . Moreover, retracting the outer sheath 56 allows the first half 74 of the anchor 72 to fully expand into the deployed second position within the occluder device 80 .
- the shaft 78 of the anchor 72 may extend through the hole in the distal end of the occluder device 80 , wherein the distal end of the occluder device 80 pinches down on the shaft 78 .
- the first half of the anchor 74 in the deployed second position may pin the occluder device 80 against the LAA wall 66 , wherein the anchor 72 effectively moors the occluder device 80 inside the LAA 64 .
- the expanded anchor 72 in the deployed second position covers a large surface area and therefore retains the occluder device 80 in an implanted position within the LAA 64 .
- the method of the present invention lowers the risk of embolization.
- the anchor cable 82 remains attached to the anchor 72 and the occluder cable 84 remains attached to the occluder device 80 in case problems arise after deployment of the occluder device 80 .
- the occluder cable 84 may be detached from the occluder device 80 and removed from the LAA 64 .
- the anchor cable 82 may be detached from the anchor 72 and removed from the LAA 64 .
- the buddy wire 62 and delivery wire 60 may also be withdrawn from the LAA 64 , leaving the occluder device 80 anchored securely in the LAA 64 by the method of the present invention.
- FIG. 17 illustrates the method of the present invention if problems arise after deployment of the occluder device 80 .
- the method comprises making a determination that the occluder device 80 is not placed in an optimal location of the LAA 64 after deployment to achieve maximum occlusion.
- the outer sheath 56 may be advanced over the occluder device 80 to the LAA wall 66 , wherein the occluder device 80 is retracted inside the outer sheath 56 using the occluder cable 82 .
- the anchor catheter 58 may then be advanced to the LAA wall 66 , wherein the first half 74 of the anchor 72 is retracted inside the anchor catheter 58 using the anchor cable 82 .
- the first half 74 of the anchor 72 retracts from the deployed second position to the contracted first position to fit inside the anchor catheter 58 .
- the outer sheath 56 containing the occluder device 80 may then be removed from the LAA 64 , or the occluder device 80 may be re-deployed in a more optimal location of the LAA 64 .
- the anchor catheter 58 may be retrieved thereafter, allowing the first half 74 of the anchor 72 to expand from the contracted first position to the deployed second position within the LAA 64 .
- the deployed anchor 72 remains inside the LAA 64 and allows for occlusion of the small hole 70 that was created by the pericardial catheter 54 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 66 .
- the anchor 72 may be released from the anchor cable 82 and deployed alone within the LAA wall 66 to plug the small hole 70 and prevent fluids from entering the pericardial space 68 .
- the delivery wire 60 and buddy wire 62 may be subsequently removed from the LAA 64 . This allows for a new anchor 72 to be placed within the LAA wall 66 using the method cited above for achieving optimal placement of the occluder device 80 within the LAA 64 .
- a second occluder device may be advanced over the inner sheath 58 and deployed within the LAA 64 using the method cited above.
- the method of the present invention allows an interventional cardiologist to quickly and cost-effectively implant the occluder device 80 into the LAA 64 using anchor 72 , safely retrieve or re-deploy the occluder device 80 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of the LAA 24 .
- the delivery wire 60 and buddy wire 62 may be removed from the LAA 64 .
- FIG. 19 illustrates yet a further aspect of the present invention, an anchoring system 90 for implanting and retrieving an occluder device within a LAA.
- the anchoring system 90 may comprise a pericardial catheter 94 , wherein the pericardial catheter 94 may be a single or double-lumen pericardial catheter.
- the anchoring system 90 may further comprise an outer sheath 96 and an inner sheath 98 .
- a balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized.
- the pericardial catheter 94 may be configured to fit a delivery wire 100 and/or a buddy wire 102 , also standardly used in the industry.
- a diameter of the delivery wire 100 may range between approximately 0.025-0.052 inches and a diameter of the buddy wire 102 may range between approximately 0.008-0.025 inches.
- the outer sheath 96 may be inserted into LAA 104 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure to a LAA wall 106 .
- the balloon occlusion may be expanded to occlude the LAA 104 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of the outer sheath 96 within the LAA 104 and allow for better imaging of the LAA 104 by an interventional cardiologist.
- the pericardial catheter 94 may be advanced through the outer sheath 96 to the LAA wall 106 .
- the buddy wire 102 is next advanced through the pericardial catheter 94 and the adjacent LAA wall 106 , wherein the buddy wire 102 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into the pericardial space 108 .
- the pericardial catheter 94 is next advanced over the buddy wire 104 and through the LAA wall 106 , penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into the pericardial space 108 .
- the pericardial catheter 94 creates a small hole 110 through the LAA wall 106 of the heart.
- the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within the pericardial space 108 via the small hole 110 .
- the delivery wire 100 may then be advanced through the pericardial catheter 94 , wherein the delivery wire 100 enters the pericardial space 108 .
- the pericardial catheter 94 may then be removed from the outer sheath 96 , leaving the delivery wire 100 and the buddy wire 102 inside the pericardial space 108 via the small hole 110 in the LAA wall 106 .
- the anchoring system 90 of the present invention further comprises an occluder device 120 and an occluder cable 124 .
- the anchoring system 90 of the present invention may be used with a diverse range of LAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices 120 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 120 may have a distal end with a hole approximately 1-5 mm in diameter.
- the occluder cable 124 may be a hollow coaxial cable standardly used in the industry.
- the occluder cable 124 may be attached to the occluder device 120 , wherein the occluder cable 124 may be used for deploying and retrieving the occluder device 120 within the LAA 104 .
- the occluder device 120 and the occluder cable 124 may encompass the inner sheath 98 , wherein the inner sheath 98 may traverse through an inner lumen of the occluder device 120 and an inner lumen of the occluder cable 124 .
- the occluder device 120 may reside between the inner sheath 98 and the outer sheath 96 .
- the inner sheath 98 may be advanced through the outer sheath 96 to the LAA wall 106 adjacent the small hole 110 .
- the delivery wire 100 may traverse through the inner sheath 98 , the occluder device 120 , and the occluder cable 124 .
- the buddy wire 102 may reside outside the inner sheath 98 and yet inside the outer sheath 96 .
- the inner sheath 98 may comprise an anchor 112 and an anchor cable 122 .
- the anchor cable 122 may be attached to the anchor 112 , wherein the anchor cable 122 may be used for deploying the anchor 112 within the LAA wall 106 .
- the anchor cable 122 may be a hollow coaxial cable standardly used in the industry.
- the anchor cable 122 and anchor 112 may encompass the delivery wire 100 , wherein the delivery wire 100 may traverse through an inner lumen of the anchor 112 and an inner lumen of the anchor cable 122 .
- the delivery wire 100 may be used to navigate the anchoring system 90 through the LAA 104 .
- the anchor 112 and anchor cable 122 may be advanced through the inner sheath 98 into the pericardial space 108 without using the delivery wire 100 .
- the buddy wire 102 may remain inside the pericardial space 108 and is a safety feature in case of emergencies.
- the buddy wire 102 allows an interventional cardiologist to advance another catheter through the LAA wall 106 and place a plug within the small hole 110 if a malfunction is observed with the anchor 112 or the occluder device 120 .
- the anchor 112 may have an elongate contracted first position ( FIG. 21A ) (e.g., straight—coil) when the delivery wire 100 is traversing the inner lumen of the anchor 112 , and a deployed second position ( FIG. 21B ) (e.g., double-coil) when the delivery wire 100 has been removed from the inner lumen of the anchor 112 .
- the delivery wire 100 when inside the inner lumen of the anchor 112 straightens the anchor 112 from its natural coiled state (deployed second position) into the elongated straight-coil (contracted first position).
- the contracted first position FIG.
- the anchor 112 has a diameter of approximately 0.5-2 mm and a length of approximately 2-40 mm.
- the anchor 112 may comprise a first coil 114 , a second coil 116 , wherein the first coil 114 and second coil 116 are connected together by a shaft 118 .
- the first coil 114 and second coil 116 expand outwards a distance of approximately 5-15 mm in diameter, the shaft 118 remains approximately 0.5-2 mm in diameter, wherein the total length of the anchor 112 is approximately 1-10 mm.
- the anchor 112 may self-expand from the contracted first position ( FIG. 21A ) to the deployed second position ( FIG. 21B ).
- the first coil 114 and second coil 116 of the anchor 112 may be shaped like circular disks, although it is contemplated that other anchor shapes may also be utilized in the present invention.
- the anchor coils 114 , 116 may comprise a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape.
- the anchor 112 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor 112 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 112 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 112 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor 112 in the contracted first position may be advanced through the inner sheath 98 using the anchor cable 122 and the delivery wire 100 , wherein the anchor 112 is further advanced through the small hole 110 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into the pericardial space 68 .
- the delivery wire 100 may then be retracted, allowing the second coil 116 of the anchor 112 to self-expand from the contracted first position to the deployed second position within the pericardial space 108 . While the second coil 116 of the anchor 112 is in the deployed second position, the shaft 118 and the first coil 114 of the anchor 112 remain temporarily in the contracted first position.
- the inner sheath 98 adjacent the LAA wall 106 may be retracted along with the delivery wire 100 , allowing the first coil 114 of the anchor 112 to self-expand from the contracted first position to a partially deployed second position within the occluder device 120 .
- the occluder device 120 remains inside the outer sheath 96 adjacent the LAA wall 106 .
- the shaft 118 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 .
- the second coil 116 of the anchor 112 remains in the deployed second position within the pericardial space 108 , wherein the first coil 114 of the anchor 112 is in the partially deployed second position within the occluder device 120 .
- the anchor 112 and occluder device 120 may be integral, wherein the occluder device 120 may be a coil occluder device.
- the integral anchor 112 and occluder device 120 may be advanced together through the inner sheath 98 , wherein the anchor 112 is implanted in the LAA wall 106 using the system 90 of the present invention described above.
- the outer sheath 96 may be retracted to allow the occluder device 120 to expand inside the LAA 104 . Moreover, retracting the outer sheath 96 allows the first coil 114 of the anchor 112 to fully expand into the deployed second position within the occluder device 120 . Thus, the shaft 118 of the anchor 112 may extend through the hole in the distal end of the occluder device 120 , wherein the distal end of the occluder device 120 pinches down on the shaft 118 .
- the first coil 114 of the anchor 112 in the deployed second position may pin the occluder device 120 against the LAA wall 106 , wherein the anchor 112 effectively moors the occluder device 120 inside the LAA 104 .
- the expanded anchor 112 in the deployed second position covers a large surface area and therefore retains the occluder device 120 in an implanted position within the LAA 104 .
- the anchoring system 90 of the present invention lowers the risk of embolization.
- the second coil 116 located within the pericardial space 108 may unwind in a clockwise fashion, while the first coil 114 located in the LAA 104 may unwind in an reverse-clockwise fashion.
- there would be counter-forces acting on the coils wherein the second coil 116 exerts proximal traction and the first coil 114 exerts distal traction against opposite sides of the LAA wall 106 .
- Such counter-forces discourage the anchor 112 from unraveling while in the deployed second position within the LAA wall 106 .
- the anchor cable 122 remains attached to the anchor 112 and the occluder cable 124 remains attached to the occluder device 120 in case problems arise after deployment of the occluder device 120 . If no problems arise and it is determined that the occluder device 120 is in an optimal location of the LAA 104 , the occluder cable 124 may be detached from the occluder device 120 and removed from the LAA 104 . Furthermore, the anchor cable 122 may be detached from the anchor 112 and removed from the LAA 104 . The buddy wire 102 and delivery wire 100 may also be withdrawn from the LAA 106 , leaving the occluder device 120 anchored securely in the LAA 104 by the anchoring system 90 of the present invention.
- FIG. 25 illustrates the anchoring system 90 of the present invention if problems arise after deployment of the occluder device 120 .
- the occluder device 120 is not placed in an optimal location of the LAA 104 after deployment to achieve maximum occlusion.
- the outer sheath 96 may be advanced over the occluder device 120 , wherein the occluder device 120 is retracted inside the outer sheath 96 using the occluder cable 124 .
- the delivery wire 100 may be further advanced through the anchor cable 112 and first coil 114 of the anchor 112 , wherein the first coil 114 retracts from the deployed second position to the contracted first position and may be retrieved inside the inner sheath 98 .
- the outer sheath 96 containing the occluder device 120 may then be removed from the LAA 104 , or the occluder device 120 may be re-deployed in a more optimal location of the LAA 104 . If the occluder device 120 is removed from the LAA 104 , the delivery wire 100 may be retrieved thereafter, allowing the first coil 114 of the anchor 112 to re-expand from the contracted first position to the deployed second position within the LAA 104 .
- the deployed anchor 112 remains inside the LAA 104 and allows for occlusion of the small hole 110 that was created by the pericardial catheter 94 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 .
- the anchor 112 may be released from the anchor cable 122 and deployed alone within the LAA wall 106 . This allows for a new anchor 112 to be placed within the LAA wall 106 using the anchoring system 90 cited above for achieving optimal placement of the occluder device 120 within the LAA 104 .
- a second occluder device may be advanced using the inner sheath 98 and deployed within the LAA 104 using the anchoring system 90 cited above.
- the anchoring system 90 of the present invention allows an interventional cardiologist to quickly and cost-effectively implant the occluder device 120 into the LAA 104 using anchor 112 , safely retrieve or re-deploy the occluder device 120 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of the LAA 104 .
- the delivery wire 100 and the buddy wire 102 may be removed from the LAA 104 .
- an anchor 112 is provided for anchoring an occluder device 120 within a LAA 104 .
- the anchor 112 may have an elongate contracted first position ( FIG. 21A ) (e.g., straight—coil) when a delivery wire 100 is traversing an inner lumen of the anchor 112 , and a deployed second position ( FIG. 21B ) (e.g., double-coil) when the delivery wire 100 has been removed from the inner lumen of the anchor 112 .
- the delivery wire 100 when inside the inner lumen of the anchor 112 straightens the anchor 112 from its natural coiled state (deployed second position) into the elongated straight-coil (contracted first position).
- the anchor 112 In the contracted first position ( FIG. 21A ), the anchor 112 has a diameter of approximately 0.5-2 mm and a length of approximately 2-40 mm.
- the anchor 112 In the deployed second position ( FIG. 21B ), the anchor 112 may comprise a first coil 114 , a second coil 116 , wherein the first coil 114 and second coil 116 are connected together by a shaft 118 .
- FIG. 21B In the deployed second position ( FIG.
- the first coil 114 and second coil 116 expand outwards a distance of approximately 5-15 mm in diameter, the shaft 118 remains approximately 0.5-2 mm in diameter, wherein the total length of the anchor 112 is approximately 1-10 mm.
- the anchor 112 may self-expand from the contracted first position ( FIG. 21A ) to the deployed second position ( FIG. 21B ).
- the first coil 114 and second coil 116 of the anchor 112 may be shaped like circular disks, although it is contemplated that other anchor shapes may also be utilized in the present invention.
- the anchor coils 114 , 116 may comprise a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape.
- the anchor 112 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor 112 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 112 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 112 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the anchor 112 of the present invention may be used with a diverse range of LAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- LAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices 120 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 120 may have a distal end with a hole approximately 1-5 mm in diameter.
- the anchor 112 in the contracted first position may be advanced through an inner sheath 98 using an anchor cable 122 and the delivery wire 100 , wherein the anchor 112 is further advanced through a small hole 110 in an LAA wall 106 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into pericardial space 68 .
- the delivery wire 100 may then be retracted, allowing the second coil 116 of the anchor 112 to self-expand from the contracted first position to the deployed second position within the pericardial space 108 . While the second coil 116 of the anchor 112 is in the deployed second position, the shaft 118 and the first coil 114 of the anchor 112 remain temporarily in the contracted first position.
- the inner sheath 98 adjacent the LAA wall 106 may be retracted along with the delivery wire 100 , allowing the first coil 114 of the anchor 112 to self-expand from the contracted first position to a partially deployed second position within the occluder device 120 .
- the occluder device 120 remains inside an outer sheath 96 adjacent the LAA wall 106 .
- the shaft 118 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 .
- the second coil 116 of the anchor 112 remains in the deployed second position within the pericardial space 108 , wherein the first coil 114 of the anchor 112 is in the partially deployed second position within the occluder device 120 .
- the anchor 112 and occluder device 120 may be integral, wherein the occluder device 120 may be a coil occluder device.
- the integral anchor 112 and occluder device 120 may be advanced together through the inner sheath 98 , wherein the anchor 112 is implanted in the LAA wall 106 using the system 90 of the present invention described above.
- the outer sheath 96 may be retracted to allow the occluder device 120 to expand inside the LAA 104 . Moreover, retracting the outer sheath 96 allows the first coil 114 of the anchor 112 to fully expand into the deployed second position within the occluder device 120 . Thus, the shaft 118 of the anchor 112 may extend through the hole in the distal end of the occluder device 120 , wherein the distal end of the occluder device 120 pinches down on the shaft 118 .
- the first coil 114 of the anchor 112 in the deployed second position may pin the occluder device 120 against the LAA wall 106 , wherein the anchor 112 effectively moors the occluder device 120 inside the LAA 104 .
- the expanded anchor 112 in the deployed second position covers a large surface area and therefore retains the occluder device 120 in an implanted position within the LAA 104 .
- the anchoring system 90 of the present invention lowers the risk of embolization.
- the second coil 116 located within the pericardial space 108 may unwind in a clockwise fashion, while the first coil 114 located in the LAA 104 may unwind in an reverse-clockwise fashion.
- there would be counter-forces acting on the coils wherein the second coil 116 exerts proximal traction and the first coil 114 exerts distal traction against opposite sides of the LAA wall 106 .
- Such counter-forces discourage the anchor 112 from unraveling while in the deployed second position within the LAA wall 106 .
- the anchor cable 122 remains attached to the anchor 112 and an occluder cable 124 remains attached to the occluder device 120 in case problems arise after deployment of the occluder device 120 . If no problems arise and it is determined that the occluder device 120 is in an optimal location of the LAA 104 , the occluder cable 124 may be detached from the occluder device 120 and removed from the LAA 104 . Furthermore, the anchor cable 122 may be detached from the anchor 112 and removed from the LAA 104 . The delivery wire 100 and/or a buddy wire 102 may also be withdrawn from the LAA 106 , leaving the occluder device 120 anchored securely in the LAA 104 by the anchoring system 90 of the present invention.
- the method of the present invention comprises providing an anchoring system 90 .
- the anchoring system 90 may comprise a pericardial catheter 94 , wherein the pericardial catheter 94 may be a single or double-lumen pericardial catheter.
- the anchoring system 90 may further comprise an outer sheath 96 and an inner sheath 98 .
- a balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized.
- the pericardial catheter 94 may be configured to fit a delivery wire 100 and/or a buddy wire 102 , also standardly used in the industry.
- a diameter of the delivery wire 100 may range between approximately 0.025-0.052 inches and a diameter of the buddy wire 102 may range between approximately 0.008-0.025 inches.
- the method of the present invention further comprises inserting the outer sheath 96 into LAA 104 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure to the LAA wall 106 .
- the balloon occlusion may be expanded to occlude the LAA 104 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of the outer sheath 96 within the LAA 104 and allow for better imaging of the LAA 104 by an interventional cardiologist.
- the pericardial catheter 94 may be advanced through the outer sheath 96 to the LAA wall 106 .
- the buddy wire 102 is next advanced through the pericardial catheter 94 and the adjacent LAA wall 106 , wherein the buddy wire 102 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into the pericardial space 108 .
- the pericardial catheter 94 is next advanced over the buddy wire 104 and through the LAA wall 106 , penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into the pericardial space 108 .
- the pericardial catheter 94 creates a small hole 110 through the LAA wall 106 of the heart.
- the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within the pericardial space 108 via the small hole 110 .
- the delivery wire 100 may then be advanced through the pericardial catheter 94 , wherein the delivery wire 100 enters the pericardial space 108 .
- the pericardial catheter 94 may then be removed from the outer sheath 96 , leaving the delivery wire 100 and the buddy wire 102 inside the pericardial space 108 via the small hole 110 in the LAA wall 106 .
- the method of the present invention further comprises providing an occluder device 120 and an occluder cable 124 .
- the method of the present invention may be used with a diverse range of LAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future.
- Specific examples of occluder devices 120 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZERTM, and AMULETTM.
- the occluder device 120 may have a distal end with a hole approximately 1-5 mm in diameter.
- the occluder cable 124 may be a hollow coaxial cable standardly used in the industry.
- the occluder cable 124 may be attached to the occluder device 120 , wherein the occluder cable 124 may be used for deploying and retrieving the occluder device 120 within the LAA 104 .
- the occluder device 120 and the occluder cable 124 may encompass the inner sheath 98 , wherein the inner sheath 98 may traverse through an inner lumen of the occluder device 120 and an inner lumen of the occluder cable 124 .
- the occluder device 120 may reside between the inner sheath 98 and the outer sheath 96 .
- the method of the present invention comprises advancing the inner sheath 98 through the outer sheath 96 to the LAA wall 106 adjacent the small hole 110 .
- the delivery wire 100 may traverse through the inner sheath 98 , the occluder device 120 , and the occluder cable 124 .
- the buddy wire 102 may reside outside the inner sheath 98 and yet inside the outer sheath 96 .
- the method of the present invention further comprises providing an anchor 112 and an anchor cable 122 .
- the anchor cable 122 may be attached to the anchor 112 , wherein the anchor cable 122 may be used for deploying the anchor 112 within the LAA wall 106 .
- the anchor cable 122 may be a hollow coaxial cable standardly used in the industry.
- the anchor cable 122 and anchor 112 may encompass the delivery wire 100 , wherein the delivery wire 100 may traverse through an inner lumen of the anchor 112 and an inner lumen of the anchor cable 122 .
- the delivery wire 100 may be used to navigate the anchoring system 90 through the LAA 104 .
- the anchor 112 and anchor cable 122 may be advanced through the inner sheath 98 into the pericardial space 108 without using the delivery wire 100 .
- the buddy wire 102 may remain inside the pericardial space 108 and is a safety feature in case of emergencies.
- the buddy wire 102 allows an interventional cardiologist to advance another catheter through the LAA wall 106 and place a plug within the small hole 110 if a malfunction is observed with the anchor 112 or the occluder device 120 .
- the anchor 112 may have an elongate contracted first position ( FIG. 21A ) (e.g., straight—coil) when the delivery wire 100 is traversing the inner lumen of the anchor 112 , and a deployed second position ( FIG. 21B ) (e.g., double-coil) when the delivery wire 100 has been removed from the inner lumen of the anchor 112 .
- the delivery wire 100 when inside the inner lumen of the anchor 112 straightens the anchor 112 from its natural coiled state (deployed second position) into the elongated straight-coil (contracted first position).
- the contracted first position FIG.
- the anchor 112 has a diameter of approximately 0.5-2 mm and a length of approximately 2-40 mm.
- the anchor 112 may comprise a first coil 114 , a second coil 116 , wherein the first coil 114 and second coil 116 are connected together by a shaft 118 .
- the first coil 114 and second coil 116 expand outwards a distance of approximately 5-15 mm in diameter, the shaft 118 remains approximately 0.5-2 mm in diameter, wherein the total length of the anchor 112 is approximately 1-10 mm.
- the anchor 112 may self-expand from the contracted first position ( FIG. 21A ) to the deployed second position ( FIG. 21B ).
- the first coil 114 and second coil 116 of the anchor 112 may be shaped like circular disks, although it is contemplated that other anchor shapes may also be utilized in the method of the present invention.
- the anchor coils 114 , 116 may comprise a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape.
- the anchor 112 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique.
- the anchor 112 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry.
- the anchor 112 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals.
- the anchor 112 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment.
- the method of the present invention comprises advancing the anchor 112 in the contracted first position ( FIG. 21A ) through the inner sheath 98 using the anchor cable 122 and the delivery wire 100 , wherein the anchor 112 is further advanced through the small hole 110 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 to extend into the pericardial space 68 .
- the delivery wire 100 may then be retracted, allowing the second coil 116 of the anchor 112 to self-expand from the contracted first position to the deployed second position within the pericardial space 108 . While the second coil 116 of the anchor 112 is in the deployed second position, the shaft 118 and the first coil 114 of the anchor 112 remain temporarily in the contracted first position.
- the method of the present invention comprises retracting the inner sheath 98 adjacent the LAA wall 106 , along with the delivery wire 100 , to allow the first coil 114 of the anchor 112 to self-expand from the contracted first position to a partially deployed second position within the occluder device 120 .
- the occluder device 120 remains inside the outer sheath 96 adjacent the LAA wall 106 .
- the shaft 118 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 .
- the second coil 116 of the anchor 112 remains in the deployed second position within the pericardial space 108 , wherein the first coil 114 of the anchor 112 is in the partially deployed second position within the occluder device 120 .
- the anchor 112 and occluder device 120 may be integral, wherein the occluder device 120 may be a coil occluder device.
- the integral anchor 112 and occluder device 120 may be advanced together through the inner sheath 98 , wherein the anchor 112 is implanted in the LAA wall 106 using the system 90 of the present invention described above.
- the method of the present invention comprises retracting the outer sheath 96 to allow the occluder device 120 to expand inside the LAA 104 . Moreover, retracting the outer sheath 96 allows the first coil 114 of the anchor 112 to fully expand into the deployed second position within the occluder device 120 .
- the shaft 118 of the anchor 112 may extend through the hole in the distal end of the occluder device 120 , wherein the distal end of the occluder device 120 pinches down on the shaft 118 .
- the first coil 114 of the anchor 112 in the deployed second position may pin the occluder device 120 against the LAA wall 106 , wherein the anchor 112 effectively moors the occluder device 120 inside the LAA 104 .
- the expanded anchor 112 in the deployed second position covers a large surface area and therefore retains the occluder device 120 in an implanted position within the LAA 104 .
- the method of the present invention lowers the risk of embolization.
- the second coil 116 located within the pericardial space 108 may unwind in a clockwise fashion, while the first coil 114 located in the LAA 104 may unwind in an reverse-clockwise fashion.
- there would be counter-forces acting on the coils wherein the second coil 116 exerts proximal traction and the first coil 114 exerts distal traction against opposite sides of the LAA wall 106 .
- Such counter-forces discourage the anchor 112 from unraveling while in the deployed second position within the LAA wall 106 .
- the anchor cable 122 remains attached to the anchor 112 and the occluder cable 124 remains attached to the occluder device 120 in case problems arise after deployment of the occluder device 120 . If no problems arise and a determination is made that the occluder device 120 is in an optimal location of the LAA 104 , the occluder cable 124 may be detached from the occluder device 120 and removed from the LAA 104 . Furthermore, the anchor cable 122 may be detached from the anchor 112 and removed from the LAA 104 . The buddy wire 102 and delivery wire 100 may also be withdrawn from the LAA 106 , leaving the occluder device 120 anchored securely in the LAA 104 by the method of the present invention.
- FIG. 25 illustrates the method of the present invention if problems arise after deployment of the occluder device 120 .
- the method comprises making a determination that the occluder device 120 is not placed in an optimal location of the LAA 104 after deployment to achieve maximum occlusion.
- the outer sheath 96 may be advanced over the occluder device 120 , wherein the occluder device 120 is retracted inside the outer sheath 96 using the occluder cable 124 .
- the delivery wire 100 may be further advanced through the anchor cable 112 and first coil 114 of the anchor 112 , wherein the first coil 114 retracts from the deployed second position to the contracted first position and may be retrieved inside the inner sheath 98 .
- the outer sheath 96 containing the occluder device 120 may then be removed from the LAA 104 , or the occluder device 120 may be re-deployed in a more optimal location of the LAA 104 . If the occluder device 120 is removed from the LAA 104 , the delivery wire 100 may be retrieved thereafter, allowing the first coil 114 of the anchor 112 to re-expand from the contracted first position to the deployed second position within the LAA 104 .
- the deployed anchor 112 remains inside the LAA 104 and allows for occlusion of the small hole 110 that was created by the pericardial catheter 94 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall 106 .
- the anchor 112 may be released from the anchor cable 122 and deployed alone within the LAA wall 106 . This allows for a new anchor 112 to be placed within the LAA wall 106 using the method cited above for achieving optimal placement of the occluder device 120 within the LAA 104 .
- a second occluder device may be advanced using the inner sheath 98 and deployed within the LAA 104 using the method cited above.
- the method of the present invention allows an interventional cardiologist to quickly and cost-effectively implant the occluder device 120 into the LAA 104 using anchor 112 , safely retrieve or re-deploy the occluder device 120 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of the LAA 104 .
- the delivery wire 100 and the buddy wire 102 may be removed from the LAA 104 .
Abstract
The present invention relates in general to anchoring systems for occluder devices, and more specifically, to an anchoring system and method for implanting an occluder device within a left atrial appendage (“LAA”) of the heart. The anchoring system is configured so that an anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of an LAA wall. The purpose of the present invention is to provide an occluder device anchor that has a low risk of embolization and/or causing injury to neighboring valve structures. An additional purpose of the present invention is to provide an anchoring system and method for implanting an occluder device within the LAA that allows for the occluder device to be retrievable after initial placement, reusable, and repositionable for an optimal final placement within the LAA.
Description
- The present invention relates in general to an anchoring system and method of attaching and retrieving an occluder device in the left atrial appendage of the heart. The purpose of the invention is to provide an anchoring system and method of attaching and retrieving an occluder device that ensures optimal placement within the left atrial appendage of the heart. A further purpose of the present invention is to provide an anchor for an occluder device that has a low risk of embolization.
- Approximately 7 million Americans have what is known as non-valvular atrial fibrillation involving complications with the left atrial appendage of the heart (hereinafter, “LAA”). The LAA is a small, windsock shaped sac in the muscle wall of the left atrium. Though uncertain as to what function the LAA performs, if anything, what is certain is that in patients with non-valvular atrial fibrillation, 90% of the thrombus formation occurs in the body of the LAA. In normal conditions, electrical impulses that control a heartbeat travel in an orderly fashion throughout the heart. These electrical impulses cause the heart to contract wherein blood in the left atrium and LAA is driven into the left ventricle with each heartbeat. However, in patients with atrial fibrillation the electrical impulses are fast and chaotic, wherein many impulses begin at the same time and spread throughout the atria. For instance, a healthy atria contracts 60-80 times per minute, while a fibrillating atria quivers at 300-400 times per minute. Problems arise when the electrical impulses do not allow the atria enough time to fully contract and efficiently displace blood into the left ventricle from the left atrium and LAA. Consequently, blood pools and collects in the LAA due to inefficient contraction of the atria and the LAA's sac-like physiological structure, causing blood clots. Strokes may ultimately occur in patients when the blood clots are pumped out of the heart and embolize to the brain. Notably, individuals with atrial fibrillation are five to seven times more likely to have a stroke than the general population.
- Treatment of atrial fibrillation typically involves oral anticoagulant therapy. Patient's taking blood thinners have noted a reduction in the risk of stroke by 65% as compared to patients without medication. The oral anticoagulant warfarin (COUMADIN®) has been traditionally utilized to minimize thrombus formation in patients with atrial fibrillation. Due to the requirement of frequent blood draws to monitor a patient's anticoagulation status, frequent interactions of the medication with either dietary changes or with other medications, and the high risk of encountering serious bleeding events, Coumadin has recently fallen into disfavor in the medical community. Newer medications including dabigatran (PRADAXA®) and rivaroxaban (XARELTO®) are also being utilized. The advantage of these newer medications are that they have less interaction with dietary changes and do not require blood draws to monitor a patient's anticoagulation status. However, these medications continue to encounter serious gastrointestinal bleeding events, are not reversible, and are extremely expensive.
- Patients who cannot tolerate anticoagulants, or are not eligible for anticoagulant treatment due to pregnancy or other medical reasons, may elect to undertake various procedures to seal off or remove the LAA. One particular procedure, known as LAA occlusion, involves implanting a device into the heart that closes the LAA. Currently, there are several different occluder devices on the market or in current testing, including the WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and the AMULET™. In each of these devices, the major technical difficulty encountered is to get the device to reliably fix itself within the LAA without embolizing or migrating out of the LAA into the systemic circulation. The reason for this is multifactorial, although primarily being related to the LAA coming in many different sizes and configurations. Some sizes and configurations of the LAA are more amenable to device closure, whereas in others, device closure can be extremely difficult—if not impossible—to safely place an occluder device within the LAA.
- The heart is comprised of three layers: (1) an inner endocardium layer; (2) a middle myocardium layer; and (3) an outer epicardium layer. The endocardium is a fragile, thin layer of tissue that lines the heart's chambers and valves. The myocardium is the thickest layer of the heart and is comprised of muscle tissue. The epicardium is a thin layer of visceral tissue. Between the heart and mediastinal space is the pericardium. The pericardium is a visceral layer of endothelium. The pericardial space lies in between the heart's epicardial surface and the pericardium. The pericardial space is filled with clear fluid that minimizes friction between the heart and other structures within the chest wall.
- Current LAA occluder devices such as the WATCHMAN® and AMPLATZER™ have barbs on the outer edge of the device that latch on circumferentially to the endocardium layer of the LAA. Using barbs to fix the occluder device onto the endocardium layer of the LAA has significant disadvantages. For example, successfully “latching” an occluder device onto the endocardial layer of the LAA may be extremely difficult and time consuming for the interventional cardiologist. Problems are compounded if initial placement of the occluder device within the LAA is less than ideal, as the occluder device cannot be fully retrieved back within the delivery system without permanently damaging the retention barbs and/or the endocardium layer. Moreover, if the occluder device embolizes out of the LAA, irreparable damage to neighboring structures such as the mitral and/or aortic valves of the heart may occur in part, due to the presence of the barbs on the occluder device. Retrieval of an embolized occluder device is further complicated by the presence of the retention barbs.
- Therefore, what is needed is an anchoring system and method for implanting an occluder device in the LAA that would allow for complete retraction and removal of the occluder device without permanently damaging the device. What is also needed is an anchoring system and method for implanting an occluder device in the LAA that provides a low risk of embolization and/or causing injury to neighboring valve structures. What is further needed is an anchoring system and method for implanting an occluder device that allows the occluder device to be positioned in multiple locations within the LAA, being able to be used in all types of LAA anatomy, and still result in optimal final placement of the occluder device within the LAA.
- Therefore, it is a principal object, feature, and/or advantage of the present invention to overcome the aforementioned deficiencies in the art and provide an anchoring system and method for implanting and retrieving an occluder device in the LAA.
- A further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting and retrieving an occluder device in the LAA that may be used with a diverse range of LAA occluder devices.
- Another object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting and recapturing an occluder device in the LAA that minimizes the risk of the occluder device embolizing or migrating following release of the occluder device into the LAA.
- Yet another object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that allows an interventional cardiologist to anchor the occluder device in multiple locations within the LAA.
- A still further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that allows the occluder device to be retrieved and adjusted within the LAA to achieve an optimal final position.
- Another object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that causes minimal or no bleeding into the pericardial space upon anchoring.
- A further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that is easy to implant and retrieve by an interventional cardiologist.
- A still further object, feature, and/or advantage of the present invention is to provide an anchoring system and method for implanting an occluder device in the LAA that allows the occluder device to be retrieved and adjusted by a interventional cardiologist within the LAA without damaging the occluder device.
- These and/or other objects, features, and/or advantages of the present invention will be apparent to those skilled in the art. The present invention is not to be limited to or by these objects, features, and advantages. No single aspect need provide each and every object, feature, or advantage.
- According to one aspect of the present invention, an anchoring system for implanting and retrieving an occluder device into a LAA comprises an outer sheath and a pericardial catheter. The pericardial catheter may be advanced through the outer sheath into the LAA, wherein the pericardial catheter penetrates a wall of the LAA and enters the pericardial space creating a small hole. A buddy wire and/or a delivery wire are advanced through the pericardial catheter to enter the pericardial space. The anchoring system of the present invention further comprises an anchor, an occluder device, and a flexible connector. The occluder device may be attached to the anchor via the connector. After the pericardial catheter is removed from the outer sheath, the anchor, the connector, and the occluder device are advanced through the outer sheath. The anchor is further advanced to penetrate the LAA wall via the small hole and extend into the pericardial space. Specifically, the anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall. Once inside the pericardial space, the anchor self-expands to implant the base in the LAA wall. The anchor is further configured to prevent the occluder device from being pushed through the small hole into the pericardial space. The outer sheath releases the occluder device into the LAA, wherein it is held in position by the anchor. By mooring the occluder device through all three layers of the LAA wall via the anchor, the risk of embolization is reduced. Another aspect of the present invention includes a method of implanting and retrieving an occluder device into a LAA using the anchoring system described above.
- According to a further aspect of the present invention, an anchoring system for implanting and retrieving an occluder device into a LAA comprises an outer sheath, a pericardial catheter, an occluder device, and an anchor. The pericardial catheter may be advanced through the outer sheath into the LAA, wherein the pericardial catheter penetrates a wall of the LAA and enters the pericardial space creating a small hole. The anchor may comprise a sheave shape with a first half and a second half connected by a shaft. The anchor may further comprise a contracted first position and a deployed second position. After the pericardial catheter is removed from the outer sheath, the occluder device, anchor catheter, and anchor are advanced through the outer sheath using the delivery wire, wherein the anchor is in the contracted first position. The anchor catheter is further advanced to penetrate the LAA wall via the small hole and extend into the pericardial space. Specifically, the anchor catheter delivers the anchor, wherein the first half of the anchor remains inside the LAA and the shaft portion and the second half of the anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall. Once inside the pericardial space, the second half of the anchor self-expands to the deployed second position within the pericardial space to implant the anchor in the LAA wall. The first half of the anchor remaining within the LAA also self-expands to the deployed second position, pinning the occluder device against the wall of the LAA. The outer sheath releases the occluder device into the LAA, wherein it is held in position by the anchor. By mooring the occluder device through all three layers of the LAA wall via the anchor, the risk of embolization is reduced. Another aspect of the present invention, a method of implanting and retrieving an occluder device into a LAA is provided. Another aspect of the present invention includes a method of implanting and retrieving an occluder device into a LAA using the anchoring system described above.
- According to yet a further aspect of the present invention, an anchoring system for implanting and retrieving an occluder device into a LAA comprises an outer sheath, a pericardial catheter, an occluder device, and an anchor. The pericardial catheter may be advanced through the outer sheath into the LAA, wherein the pericardial catheter penetrates a wall of the LAA and enters the pericardial space creating a small hole. A buddy wire and/or a delivery wire are advanced through the pericardial catheter to enter the pericardial space. After the pericardial catheter is removed from the outer sheath, an anchor catheter, the occluder device, and the anchor are then advanced through the outer sheath using the delivery wire. While in a straight-coil configuration, the anchor penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall to extend into the pericardial space. When the delivery wire is retrieved, the anchor self-expands into a two-disc shape, wherein a first coil resides within the LAA and a second coil resides within the pericardial space. The outer sheath releases the occluder device into the LAA, wherein it is pinned against the LAA wall by the anchor. By mooring the occluder device through all three layers of the LAA wall via the anchor, the risk of embolization is reduced. Another aspect of the present invention includes a method of implanting and retrieving an occluder device into a LAA using the anchoring system described above.
- Different aspects may meet different objects of the invention. Other objectives and advantages of this invention will be more apparent in the following detailed description taken in conjunction with the figures. The present invention is not to be limited by or to these objects, aspects, or figures.
-
FIGS. 1-26 represent examples of the anchoring system, anchor, and method of the present invention. -
FIG. 1 is a view of an outer sheath and pericardial catheter of an anchoring system of the present invention and method for implanting and retrieving an occluder device within a LAA. -
FIG. 2 is a view of an anchor, connector, and occluder device of the anchoring system and method ofFIG. 1 . -
FIG. 3 is a view of an anchor of the anchoring system and method of claim 1, wherein the anchor comprises anchor tines. -
FIG. 3A is an end-view of the anchor ofFIG. 3 , wherein anchor tines are in a contracted first position. -
FIG. 3B is an end-view of the anchor ofFIG. 3 , wherein the anchor tines are in a deployed second position. -
FIG. 4 is a view of an anchor of the anchoring system and method ofFIG. 1 , wherein the anchor comprises a coil-wire. -
FIG. 4A is an end-view of the anchor ofFIG. 4 , wherein a coil-wire is in a contracted first position constrained within an inner sheath. -
FIG. 4B is an end-view of the anchor ofFIG. 4 , wherein the coil-wire is in a deployed second position within the pericardial space. -
FIG. 5 is a view of the anchoring system and method ofFIG. 1 , wherein the anchor and the occluder device are advanced into the LAA. -
FIG. 6 is a view of the anchoring system and method ofFIG. 5 , wherein the anchor is advanced through the LAA wall. -
FIG. 7 is a view of the anchoring system and method ofFIG. 6 , wherein the occluder device is released from the inner sheath and positioned within the LAA. -
FIG. 8 is a view of the anchoring system and method ofFIG. 7 , wherein the occluder device is retrieved inside the inner sheath and the anchor is left implanted in the LAA wall, sealing up the small hole created by the pericardial catheter. -
FIG. 9 is a view of the anchoring system and method ofFIG. 8 , wherein the anchor is retracted from the LAA wall and the anchor and the occluder device are retrieved inside the inner sheath. -
FIG. 10 is a view of an outer sheath and a pericardial catheter of another aspect of an anchoring system of the present invention and method for implanting and retrieving an occluder device within a LAA. -
FIG. 11 is a view of an outer sheath, anchor catheter, and inner dilator of the anchoring system and method ofFIG. 10 , wherein the inner dilator and anchor catheter penetrate the LAA wall. -
FIG. 12 is a view the anchoring system and method ofFIG. 10 , wherein an occluder device and an anchor are advanced through the outer sheath and anchor catheter, respectively. -
FIG. 13 is a frontal-side view of the anchor of the anchoring system and method ofFIG. 10 , wherein the anchor comprises a sheave shape with a first half, a second half, and a shaft connecting the two halves. -
FIG. 13A is a side-view of the anchor ofFIG. 13 , wherein the anchor is in a contracted first position. -
FIG. 13B is a side-view of the anchor ofFIG. 13 , wherein the anchor is in a deployed second position. -
FIG. 14 is a view of the anchoring system and method ofFIG. 1 , wherein the second half of the anchor is deployed in the pericardial space. -
FIG. 15 is a view of the anchoring system and method ofFIG. 1 , wherein the first half of the anchor is partially deployed in the occluder device. -
FIG. 16 is a view of the anchoring system and method ofFIG. 1 , wherein the occluder device is released from the outer sheath and the second half of the anchor fully deployed to pin the occluder device against the LAA wall. -
FIG. 17 is a view of the anchoring system and method ofFIG. 1 if problems arise after deployment of the occluder device, wherein the occluder device is retracted inside the outer sheath and the first half of the anchor is retracted inside the anchor catheter. -
FIG. 18 is a view of the anchoring system and method ofFIG. 1 if problems arise after deployment of the occluder device, wherein the anchor is left implanted in the LAA wall. -
FIG. 19 is a view of an outer sheath and pericardial catheter of another aspect of an anchoring system of the present invention and method for implanting and retrieving an occluder device within a LAA. -
FIG. 20 is a view the anchoring system and method ofFIG. 19 , wherein an occluder device is advanced through the outer sheath and an anchor is advanced through the anchor catheter. -
FIG. 21A is a side-view of the anchor ofFIG. 20 , wherein the anchor is in a contracted first position. -
FIG. 21B is a side-view of the anchor ofFIG. 20 , wherein the anchor is in a deployed second position comprising a double-coiled shape with a first half, a second half, and a shaft connecting the two halves. -
FIG. 22 is a view of the anchoring system and method ofFIG. 19 , wherein the second half of the anchor is deployed in the pericardial space. -
FIG. 23 is a view of the anchoring system and method ofFIG. 19 , wherein the first half of the anchor is partially deployed in the occluder device. -
FIG. 24 is a view of the anchoring system and method ofFIG. 19 , wherein the occluder device is released from the outer sheath and the first half of the anchor is fully deployed to pin the occluder device against the LAA wall. -
FIG. 25 is a view of the anchoring system and method ofFIG. 19 if problems arise after deployment of the occluder device, wherein the occluder device is retracted inside the outer sheath and the first half of the anchor is retracted inside the anchor catheter. -
FIG. 26 is a view of the anchoring system and method ofFIG. 19 if problems arise after deployment of the occluder device, wherein the anchor is left implanted in the LAA wall. -
FIG. 1 illustrates one aspect of the present invention, ananchoring system 10 for implanting and retrieving an occluder device within a LAA. The anchoringsystem 10 may comprise apericardial catheter 14, wherein thepericardial catheter 14 may be a single or double-lumen pericardial catheter. The anchoringsystem 10 may further comprise anouter sheath 16 and aninner sheath 18. A balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized. The single or double-lumenpericardial catheter 14 may be configured to fit adelivery wire 20 and/or abuddy wire 22, also standardly used in the industry. A diameter of thedelivery wire 20 may range between approximately 0.025-0.052 inches and a diameter of thebuddy wire 22 may range between approximately 0.008 0.025 inches. - Further illustrated in
FIG. 1 , theouter sheath 16 may be inserted intoLAA 24 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude theLAA 24 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of theouter sheath 16 within theLAA 24 and allow for better imaging of theLAA 24 by an interventional cardiologist. Thepericardial catheter 14 may be advanced through theouter sheath 16, wherein thepericardial catheter 14penetrates LAA wall 26 and enterspericardial space 28. Specifically, thepericardial catheter 14 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26. Thus, thepericardial catheter 14 creates asmall hole 30 through theLAA wall 26 of the heart. If utilized, the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of bleeding and fluid accumulating within thepericardial space 28 via thesmall hole 30. While thepericardial catheter 14 remains inside thepericardial space 28 via thesmall hole 30, thedelivery wire 20 and/or thebuddy wire 22 may be advanced through thepericardial catheter 14, wherein thedelivery wire 20 and/or thebuddy wire 22 enter thepericardial space 28. Thebuddy wire 22 remains inside thepericardial space 28 and is a safety feature in case of emergencies. Thebuddy wire 22 allows a interventional cardiologist to advance another catheter through theLAA wall 26 and place a plug within thesmall hole 30 if a malfunction is observed with theanchor 32 or theoccluder device 36. Thepericardial catheter 14 may then be removed from theouter sheath 16, leaving thedelivery wire 20 and/or thebuddy wire 22 inside thepericardial space 28 via thesmall hole 30 in theLAA wall 26. - Illustrated in
FIG. 2 , the anchoringsystem 10 of the present invention further comprises ananchor 32, anoccluder device 36, and aconnector 38. It is contemplated that theanchoring system 10 of the present invention may be used with a diverse range of LAA occluder devices such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples of occluder devices that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. - Further illustrated in
FIG. 2 , theoccluder device 36 is connected to theanchor 32 via theconnector 38. Theconnector 38 may be comprised of stainless steel, platinum, Nitinol, Elgiloy, or other materials standardly used in the industry. Theconnector 38 may be square, flat, rectangular, round, spherical, coiled, ovular, a combination thereof, or any other shape. Theconnector 38 may be approximately 0.5 mm-10 mm in length and approximately 0.5 mm-10 mm in width. It is intended that theconnector 38 provide flexibility between theanchor 32 and theoccluder device 36. This flexibility may be achieved via an articulating joint, such as a ball-and-socket joint 44, shown inFIG. 2 . The ball-and-socket joint 44 ofFIG. 2 is illustrated for example purposes only. It is not intended that theconnector 38 of the present invention be limited to a ball-and-socket joint 44. Rather, it is intended that other articulating connectors standardly used in the industry may also be utilized, such as hinge joints, pivot joints, ellipsoid joints, gliding joints, saddle joints, and others. It is important that theconnector 38 provide flexibility between theoccluder device 36 and theanchor 32 to allow for multiple insertion sites within theLAA 24, thus, ensuring theoccluder device 36 is properly positioned within theLAA 24 once deployed. Furthermore, theconnector 38 may allow an interventional cardiologist via a cable (not shown) to conveniently attach theoccluder device 36 to theanchor 32, release theoccluder device 36 from theanchor 32, and reattach theoccluder device 36 to theanchor 32 without damaging theoccluder device 36. - Illustrated in
FIG. 3 , theanchor 32 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape. The length of theanchor 32 may be approximately 1-10 mm, wherein the width of theanchor 32 may be approximately 1-20 mm. Theanchor 32 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 32 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - Further illustrated in
FIG. 3 , theanchor 32 may comprise a plurality of self-expandinganchor tines 39, wherein the plurality may comprise 2-10 tines. The anchor tines 39 may be approximately 5-20 mm in length and approximately 0.01-1.5 mm in width. The anchor tines 39 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. The anchor tines 39 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. The anchor tines 39 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that theanchor tines 39 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - Alternatively, the
anchor 32 of the present invention may comprise a self-expanding coil-wire 40 instead of theanchor tines 39 as illustrated inFIG. 4 . The coil-wire 40 may be approximately 5-25 mm in length and 0.01-1.5 mm in width. The coil-wire 40 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. The coil-wire 40 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. The coil-wire 40 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the coil-wire 40 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - The
anchor 32 may have a contracted first position (FIGS. 3A, 4A ) and a deployed second position (FIGS. 3B, 4B ). When theanchor tines 39 are utilized, theanchor tines 39 may expand outwards a distance of approximately 2-20 mm in diameter in the deployed second position (FIG. 3B ). Alternatively when the coil-wire 40 is utilized, the coil-wire may have a circular diameter of 0.01-1.5 mm in the contracted first position (FIG. 4A ), and may have a circular diameter of approximately 5-20 mm in the deployed second position (FIG. 4B ). However, it is contemplated that the diameter of the contracted first position and deployed second position of the coil-wire 40 may have any shape compatible with theLAA 24. - Illustrated in
FIG. 5 , theinner sheath 18 is advanced up to and adjacent theLAA wall 26. Theanchor 32, theconnector 38, and theoccluder device 36 are next advanced through theinner sheath 18 using thedelivery wire 20, wherein theanchor 32 resides adjacent thesmall hole 30 in theLAA wall 26. - Illustrated in
FIG. 6 , theanchor 32, theconnector 38, and theoccluder device 36 are further advanced through theinner sheath 18 using thedelivery wire 20, wherein theanchor 32 penetrates theLAA wall 26 via thesmall hole 30 and extends into thepericardial space 28. Specifically, theanchor 32 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26. Once inside thepericardial space 28, theanchor 32 self-expands from the contracted first position (FIGS. 3A, 4A ) to the deployed second position (FIGS. 3B, 4B ). - Illustrated in
FIG. 7 , theinner sheath 18 is retracted inside theouter sheath 16 after theanchor 32 has been implanted in theLAA wall 26. This effectively releases theoccluder device 36 into theLAA 24. The expandedanchor 32 in the deployed second position (FIGS. 3B, 4B ) covers a large surface area and therefore retains theoccluder device 36 in an implanted position within theLAA 24. Moreover, by anchoring theoccluder device 36 via theanchor 32 through all three layers of theLAA wall 26—instead of merely latching onto the thin endocardium layer—theanchoring system 10 of the present invention lowers the risk of embolization. -
FIGS. 8-9 illustrate theanchoring system 10 of the present invention if problems arise after deployment of theoccluder device 36. For instance, it may be determined that theoccluder device 36 is not placed in an optimal location of theLAA 24 after deployment to achieve maximum occlusion. The anchoringsystem 10 of the present invention offers two solutions to overcome these problems. - The first solution is illustrated in
FIG. 8 , wherein an interventional cardiologist may use a cable (not shown) to detach 42 theoccluder device 36 from theanchor 32 viaconnector 38. Theoccluder device 36 is then retrieved inside theinner sheath 18 via the cable. Theanchor 32 is expendable and may be left implanted in theLAA wall 26 where it causes no harm to the patient. Anew anchor 32 is then connected to theoccluder device 36 via theconnector 38, and the anchoring steps repeated until optimal placement of theoccluder device 36 within theLAA 24 is achieved. - The second solution is illustrated in
FIG. 9 , wherein theoccluder device 36 is retrieved inside theinner sheath 18 via a cable (not shown). Theinner sheath 18 is then advanced to envelope theanchor 32 and press up against theLAA wall 26. While theinner sheath 18 is pressed up against theLAA wall 26, theanchor 32 is pulled back through theLAA wall 26, into theLAA 24, and retrieved 46 inside theinner sheath 18 via the cable. Theanchor 32 is designed to retract from the deployed second position (FIGS. 3B, 4B ) into the contracted first position (FIGS. 3A, 4A ) without tearing or ripping theLAA wall 26 as theanchor 32 is retrieved inside theinner sheath 18. Thus, the anchoringsystem 10 of the present invention allows an interventional cardiologist to quickly and cost-effectively implant theoccluder device 36 into theLAA 24 usinganchor 32, safely retrieve theoccluder device 36 andanchor 32 if initial placement was improper or if complications arise, and then reuse and re-implant theoccluder device 36 andanchor 32 in an optimal location of theLAA 24. Ultimately after optimal placement of the occluder device within the LAA is achieved, thedelivery wire 20 andbuddy wire 22 are removed from the LAA via the outer 16 sheath. Theouter sheath 16 may be subsequently removed from theLAA 24 via the left atrium proper of the heart. - In another aspect of the present invention, an
anchor 32 is provided for anchoring anoccluder device 36 within theLAA 24. As illustrated inFIG. 3 , theanchor 32 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape. The length of theanchor 32 may be approximately 1-10 mm, wherein the width of theanchor 32 may be approximately 1-20 mm. Theanchor 32 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 32 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - Illustrated in
FIG. 2 , theanchor 32 is further configured to connect to anoccluder device 36 via aconnector 38. Theconnector 38 may be comprised of stainless steel, platinum, Nitinol, Elgiloy, or other materials standardly used in the industry. Theconnector 38 may be square, flat, rectangular, round, spherical, coiled, ovular, a combination thereof, or any other shape. Theconnector 38 may be approximately 0.5 mm-10 mm in length and approximately 0.5 mm-10 mm in width. It is intended that theconnector 38 provide flexibility between theanchor 32 and theoccluder device 36. This flexibility may be achieved via an articulating joint, such as a ball-and-socket joint 44, shown inFIG. 2 . The ball-and-socket joint 44 ofFIG. 2 is illustrated for example purposes only. It is not intended that theconnector 38 of the present invention be limited to a ball-and-socket joint 44. Rather, it is intended that other articulating connectors standardly used in the industry may also be utilized, such as hinge joints, pivot joints, ellipsoid joints, gliding joints, saddle joints, and others. It is important that theconnector 38 provide flexibility between theoccluder device 36 and theanchor 32 to allow for multiple insertion sites within theLAA 24, thus, ensuring theoccluder device 36 is properly positioned within theLAA 24 once deployed. Furthermore, theconnector 38 may allow an interventional cardiologist via a cable (not shown) to conveniently attach theoccluder device 36 to theanchor 32, release theoccluder device 36 from theanchor 32, and reattach theoccluder device 36 to theanchor 32 without damaging theoccluder device 36. - Further illustrated in
FIG. 3 , theanchor 32 may comprise a plurality of self-expandinganchor tines 39, wherein the plurality may comprise 2-10 tines. The anchor tines 39 may be approximately 5-20 mm in length and approximately 0.01-1.5 mm in width. The anchor tines 39 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. The anchor tines 39 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. The anchor tines 39 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that theanchor tines 39 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - Alternatively, the
anchor 32 of the present invention may comprise a self-expanding coil-wire 40 instead of theanchor tines 39 as illustrated inFIG. 4 . The coil-wire 40 may be approximately 5-25 mm in length and 0.01-1.5 mm in width. The coil-wire 40 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. The coil-wire 40 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. The coil-wire 40 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the coil-wire 40 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - The
anchor 32 may have a contracted first position (FIGS. 3A, 4A ) and a deployed second position (FIGS. 3B, 4B ). When theanchor tines 39 are utilized, theanchor tines 39 may expand outwards a distance of approximately 2-20 mm in diameter in the deployed second position (FIG. 3B ). Alternatively when the coil-wire 40 is utilized, the coil-wire may have a circular diameter of 0.01-1.5 mm in the contracted first position (FIG. 4A ), and may have a circular diameter of approximately 5-20 mm in the deployed second position (FIG. 4B ). However, it is contemplated that the diameter of the contracted first position and deployed second position of the coil-wire 40 may have any shape compatible with theLAA 24. - Illustrated in
FIG. 6 , theanchor 32 is configured to penetrate theLAA wall 26 via a pre-madesmall hole 30 through the LAA wall. Specifically, theanchor 32 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26. Theanchor 32 extends into thepericardial space 28, wherein theanchor 32 self-expands from the contracted first position (FIGS. 3A, 4A ) to the deployed second position (FIGS. 3B, 4B ). The expandedanchor 32 in the deployed second position (FIGS. 3B, 4B ) covers a large surface area and therefore retains theoccluder device 36 in an implanted position within theLAA 24. Moreover, by anchoring theoccluder device 36 via theanchor 32 through all three layers of theLAA wall 26—instead of merely latching onto the thin endocardium layer—theanchor 32 of the present invention lowers the risk of embolization. - In yet another aspect of the present invention, a method of implanting and retrieving an occluder device within a LAA is illustrated in
FIG. 1 . The method of the present invention comprises providing ananchoring system 10. The anchoringsystem 10 comprises apericardial catheter 14, wherein thepericardial catheter 14 may be a single or double-lumen pericardial catheter. The anchoringsystem 10 may further comprise anouter sheath 16 and aninner sheath 18. A balloon-occlusion catheter may also be utilized in the present invention. However, it is intended that other catheters standard in the industry may also be utilized. Thepericardial catheter 14 may be configured to fit adelivery wire 20 and/or abuddy wire 22, also standardly used in the industry. A diameter of thedelivery wire 20 may range between approximately 0.025-0.052 inches and a diameter of thebuddy wire 22 may range between approximately 0.008-0.025 inches. - Further illustrated in
FIG. 1 , the method of the present invention comprises inserting theouter sheath 16 intoLAA 24 via the left atrium proper of the heart. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude theLAA 24 from the left atrium proper. Next, thepericardial catheter 14 may be advanced through theouter sheath 16, wherein thepericardial catheter 14penetrates LAA wall 26 and enterspericardial space 28. Specifically, thepericardial catheter 14 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26. Thus, thepericardial catheter 14 creates asmall hole 30 through theLAA wall 26 of the heart. If utilized, the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within thepericardial space 28 via thesmall hole 30. While thepericardial catheter 14 remains inside thepericardial space 28 via thesmall hole 30, thedelivery wire 20 and thebuddy wire 22 may be advanced through thepericardial catheter 14, wherein thedelivery wire 20 and thebuddy wire 22 enter thepericardial space 28. Thebuddy wire 22 remains inside thepericardial space 28 and is a safety feature in case of emergencies. Thebuddy wire 22 allows an interventional cardiologist to advance another catheter through theLAA wall 26 and place a plug within thesmall hole 30 if a malfunction is observed with theanchor 32 or theoccluder device 36. Thepericardial catheter 14 may then be removed from theouter sheath 16, leaving thedelivery wire 20 and thebuddy wire 22 inside thepericardial space 28 via thesmall hole 30 in theLAA wall 26. - Illustrated in
FIG. 2 , the method of the present invention further comprises providing ananchor 32, anoccluder device 36, and aconnector 38. It is contemplated that the method of the present invention may be used with a diverse range of LAA occluder devices such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples of occluder devices that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. - Further illustrated in
FIG. 2 , the method of the present invention comprises connecting theoccluder device 36 to theanchor 32 via theconnector 38. Theconnector 38 may be comprised of stainless steel, platinum, Nitinol, Elgiloy, or other materials standardly used in the industry. Theconnector 38 may be square, flat, rectangular, round, spherical, coiled, ovular, a combination thereof, or any other shape. Theconnector 38 may be approximately 0.5 mm-10 mm in length and approximately 0.5 mm-10 mm in width. It is intended that theconnector 38 provide flexibility between theanchor 32 and theoccluder device 36. This flexibility may be achieved via an articulating joint, such as a ball-and-socket joint 44, shown inFIG. 2 . The ball-and-socket joint 44 ofFIG. 2 is illustrated for example purposes only. It is not intended that theconnector 38 of the present invention be limited to a ball-and-socket joint 44. Rather, it is intended that other articulating connectors standardly used in the industry may also be utilized, such as hinge joints, pivot joints, ellipsoid joints, gliding joints, saddle joints, and others. It is important that theconnector 38 provide flexibility between theoccluder device 36 and theanchor 32 to allow for multiple insertion sites within theLAA 24, thus, ensuring theoccluder device 36 is properly positioned within theLAA 24 once deployed. Furthermore, theconnector 38 may allow an interventional cardiologist via a cable (not shown) to conveniently attach theoccluder device 36 to theanchor 32, release theoccluder device 36 from theanchor 32, and reattach theoccluder device 36 to theanchor 32 without damaging theoccluder device 36. - Illustrated in
FIG. 3 , theanchor 32 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape. The length of theanchor 32 may be approximately 1-10 mm, wherein the width of theanchor 32 may be approximately 1-20 mm. Theanchor 32 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 32 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - Further illustrated in
FIG. 3 , theanchor 32 may comprise a plurality of self-expandinganchor tines 39, wherein the plurality may comprise 2-10 tines. The anchor tines 39 may be approximately 5-20 mm in length and approximately 0.01-1.5 mm in width. The anchor tines 39 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. The anchor tines 39 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. The anchor tines 39 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that theanchor tines 39 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - Alternatively, the
anchor 32 of the present invention may comprise a self-expanding coil-wire 40 instead of theanchor tines 39 as illustrated inFIG. 4 . The coil-wire 40 may be approximately 5-25 mm in length and 0.01-1.5 mm in width. The coil-wire 40 may be circular in cross-section, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. The coil-wire 40 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. The coil-wire 40 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. It is also contemplated that the coil-wire 40 may comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. - The
anchor 32 may have a contracted first position (FIGS. 3A, 4A ) and a deployed second position (FIGS. 3B, 4B ). When theanchor tines 39 are utilized, theanchor tines 39 may expand outwards a distance of approximately 2-20 mm in diameter in the deployed second position (FIG. 3B ). Alternatively when the coil-wire 40 is utilized, the coil-wire may have a circular diameter of 0.01-1.5 mm in the contracted first position (FIG. 4A ), and may have a circular diameter of approximately 5-20 mm in the deployed second position (FIG. 4B ). However, it is contemplated that the diameter of the contracted first position and deployed second position of the coil-wire 40 may have any shape compatible with theLAA 24. - Illustrated in
FIG. 5 , the method of the present invention further comprises advancing theinner sheath 18 up to and adjacent theLAA wall 26. Theanchor 32, theconnector 38, and theoccluder device 36 are next advanced through theinner sheath 18 using thedelivery wire 20, wherein theanchor 32 resides adjacent thesmall hole 30 in theLAA wall 26. - Illustrated in
FIG. 6 , the method of the present invention comprises further advancing theanchor 32, theanchor tines 39, theconnector 38, and theoccluder device 36 through theinner sheath 18 using thedelivery wire 20, wherein theanchor 32 penetrates theLAA wall 26 via thesmall hole 30 and extends into thepericardial space 28. Specifically, theanchor 32 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26. Once inside thepericardial space 28, theanchor 32 self-expands from the contracted first position (FIGS. 3A, 4A ) to the deployed second position (FIGS. 3B, 4B ). - Illustrated in
FIG. 7 , the method of the present invention further comprises retracting theinner sheath 18 inside theouter sheath 16 after theanchor 32 has been implanted in theLAA wall 26. This effectively releases theoccluder device 36 into theLAA 24. The expandedanchor 32 in the deployed second position (FIGS. 3B, 4B ) covers a large surface area and therefore retains theoccluder device 36 in an implanted position within theLAA 24. Moreover, by anchoring theoccluder device 36 via theanchor 32 through all three layers of theLAA wall 26—instead of merely latching onto the thin endocardium layer—theanchoring system 10 of the present invention lowers the risk of embolization. -
FIGS. 8-9 illustrate the method of the present invention, further comprising making a determination whether a problem has arisen after deployment of theoccluder device 36. For example, it may be determined that theoccluder device 36 is not placed in an optimal location of theLAA 24 after deployment to achieve maximum occlusion. The method of the present invention offers two alternative solutions to overcome these problems. - The first solution is illustrated in
FIG. 8 , wherein an interventional cardiologist may use a cable (not shown) to detach 42 theoccluder device 36 from theanchor 32 viaconnector 38. Theoccluder device 36 is then retrieved inside theinner sheath 18 via the cable. Theanchor 32 is expendable and may be left implanted in theLAA wall 26 where it causes no harm to the patient. Anew anchor 32 is then connected to theoccluder device 36 via theconnector 38, and the anchoring steps repeated until optimal placement of theoccluder device 36 within theLAA 24 is achieved. - The second solution is illustrated in
FIG. 9 , wherein theoccluder device 36 is retrieved inside theinner sheath 18 via a cable (not shown). Theinner sheath 18 is then advanced to envelope theanchor 32 and press up against theLAA wall 26. While theinner sheath 18 is pressed up against theLAA wall 26, theanchor 32 is pulled back through theLAA wall 26, into theLAA 24, and retrieved 46 inside theinner sheath 18 via the cable. Theanchor 32 is designed to retract from the deployed second position (FIGS. 3B, 4B ) into the contracted first position (FIGS. 3A, 4A ) without tearing or ripping theLAA wall 26 as theanchor 32 is retrieved inside theinner sheath 18. Thus, the method of the present invention allows an interventional cardiologist to quickly and cost-effectively implant theoccluder device 36 into theLAA 24 usinganchor 32, safely retrieve theoccluder device 36 andanchor 32 if initial placement was improper or if complications arise, and then reuse and re-implant thesame occluder device 36 andanchor 32 in an optimal location of theLAA 24. Ultimately after optimal placement of the occluder device within the LAA is achieved, thedelivery wire 20 andbuddy wire 22 are removed from the LAA via theouter sheath 16. Theouter sheath 16 may be subsequently removed from theLAA 24 via the left atrium proper of the heart. -
FIG. 10 illustrates a further aspect of the present invention, ananchoring system 50 for implanting and retrieving an occluder device within a LAA. The anchoringsystem 50 may comprise apericardial catheter 54, wherein thepericardial catheter 54 may be a single or double-lumen pericardial catheter. The anchoringsystem 50 may further comprise anouter sheath 56. A balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized. Thepericardial catheter 54 may be configured to fit adelivery wire 60 and/or abuddy wire 62, also standardly used in the industry. A diameter of thedelivery wire 60 may range between approximately 0.025-0.052 inches and a diameter of thebuddy wire 62 may range between approximately 0.008-0.025 inches. - Further illustrated in
FIG. 10 , theouter sheath 56 may be inserted intoLAA 64 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude theLAA 64 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of theouter sheath 56 within theLAA 64 and allow for better imaging of theLAA 64 by an interventional cardiologist. Thepericardial catheter 54 may be advanced through theouter sheath 56 to theLAA wall 66. Thebuddy wire 62 is next advanced through thepericardial catheter 54 and theadjacent LAA wall 66, wherein thebuddy wire 62 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26 to extend into thepericardial space 68. Thepericardial catheter 54 is next advanced over thebuddy wire 62 and through theLAA wall 66, penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66 to extend into thepericardial space 68. Thus, thepericardial catheter 54 creates asmall hole 70 through theLAA wall 66 of the heart. If utilized, the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within thepericardial space 68 via thesmall hole 70. While thepericardial catheter 54 remains inside thepericardial space 68 via thesmall hole 70, thedelivery wire 60 may then be advanced through thepericardial catheter 54, wherein thedelivery wire 60 enters thepericardial space 68. Thepericardial catheter 54 may then be removed from theouter sheath 56, leaving thedelivery wire 60 and thebuddy wire 62 inside thepericardial space 68 via thesmall hole 70 in theLAA wall 66. - Illustrated in
FIG. 11 , the anchoringsystem 50 of the present invention further comprises ananchor catheter 58 and an inner dilator 86, wherein the inner dilator 86 includes a pointeddistal end 88. The inner dilator 86 may be configured to encompass thedelivery wire 60, wherein thedelivery wire 60 may traverse through an inner lumen of the inner dilator 86. Theanchor catheter 58 and the inner dilator 86 may be advanced through theouter sheath 56 to theLAA wall 66 adjacent thesmall hole 70. Particularly, thedelivery wire 60 may traverse through the anchor catheter 52 and the inner dilator 86. Thebuddy wire 62 may reside outside theanchor catheter 58 and yet inside theouter sheath 56. Using the pointeddistal end 88 of the inner dilator 86, the inner dilator 86 and the anchor catheter 52 may be further advanced through thesmall hole 70 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66. Thus, the pointeddistal end 88 of the inner dilator 86, along with a distal end of the anchor catheter 52, extends into thepericardial space 68. The inner dilator 86 may be subsequently removed from theanchor catheter 58, wherein the distal end of theanchor catheter 58 remains extending into thepericardial space 68. - Illustrated in
FIG. 12 , the anchoringsystem 50 of the present invention further comprises anoccluder device 80 and anoccluder cable 84. It is contemplated that theanchoring system 50 of the present invention may be used with a diverse range ofLAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples ofoccluder devices 80 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. In the present invention, theoccluder device 80 may have a distal end with a hole approximately 1-5 mm in diameter. As shown inFIG. 12 , theoccluder cable 84 may be a hollow coaxial cable standardly used in the industry. Theoccluder cable 84 may be attached to theoccluder device 80, wherein theoccluder cable 84 may be used for deploying and retrieving theoccluder device 80 within theLAA 64. Theoccluder device 80 and theoccluder cable 84 may encompass theanchor catheter 58, wherein theanchor catheter 58 may traverse through an inner lumen of theoccluder device 80 and an inner lumen of theoccluder cable 84. Theoccluder device 80 may reside between theanchor catheter 58 and theouter sheath 56. - As further shown in
FIG. 12 , the anchoringcatheter 58 may comprise ananchor 72 and ananchor cable 82. Theanchor cable 82 may be attached to theanchor 72, wherein theanchor cable 82 may be used for deploying theanchor 72 within theLAA wall 66. Theanchor cable 82 may be a hollow coaxial cable standardly used in the industry. Theanchor cable 82 andanchor 72 may encompass thedelivery wire 60, wherein thedelivery wire 60 may traverse through an inner lumen of theanchor 72 and an inner lumen of theanchor cable 82. Thedelivery wire 60 may be used to navigate theanchoring system 50 through theLAA 64. Alternatively, theanchor 72 andanchor cable 82 may be advanced through theanchor catheter 58 into thepericardial space 68 without using thedelivery wire 60. Thebuddy wire 62 may remain inside thepericardial space 68 and is a safety feature in case of emergencies. Thebuddy wire 62 allows an interventional cardiologist to advance another catheter through theLAA wall 66 and place a plug within thesmall hole 70 if a malfunction is observed with theanchor 72 or theoccluder device 80. - Illustrated in
FIG. 13 , theanchor 72 may be shaped like a sheave, comprising afirst half 74, asecond half 76, and ashaft 78 connecting thefirst half 74 to thesecond half 76, although it is contemplated that other anchor shapes may also be utilized in the present invention. Theanchor 72 may be comprised of wire, wherein thefirst half 74 andsecond half 76 of theanchor 72 comprise wire mesh, further wherein theshaft 78 may comprise a single wire connecting the first half 75 wire mesh and thesecond half 76 wire mesh. Theanchor 72 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape, and may be comprised of single or multiple wires. Theanchor 72 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. Theanchor 72 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 72 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. Theanchor 72 may have a lumen wherein thedelivery wire 60 traverses therein, alternatively, theanchor 72 may not have a lumen. Theanchor 72 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. - Illustrated in
FIGS. 13A-B , theanchor 72 may have a contracted first position (FIG. 13A ) and a deployed second position (FIG. 13B ). In the contracted first position (FIG. 13A ), thefirst half 74,second half 76, andshaft 78 of theanchor 72 have a diameter of approximately 1-5 mm and a length of approximately 5-55 mm. In the deployed second position (FIG. 13B ), thefirst half 74 andsecond half 76 of theanchor 72 may expand outwards a distance of approximately 5-25 mm in diameter, wherein theshaft 78 remains approximately 1-5 mm in diameter. Theanchor 72 may self-expand from the contracted first position (FIG. 13A ) to the deployed second position (FIG. 13B ). - Illustrated in
FIG. 14 , theanchor 72 in the contracted first position (FIG. 13A ) may be advanced through theanchor catheter 58 using theanchor cable 82 and thedelivery wire 60, wherein theanchor 72 extends into thepericardial space 68. Theanchor catheter 58 may then be retracted, allowing thesecond half 76 of theanchor 72 to self-expand from the contracted first position to the deployed second position within thepericardial space 68. While thesecond half 76 of theanchor 72 is in the deployed second position, theshaft 78 and thefirst half 74 of theanchor 72 remain temporarily inside theanchor catheter 58. - Illustrated in
FIG. 15 , theanchor catheter 58 may be further retracted, allowing thefirst half 74 of theanchor 72 to self-expand from the contracted first position to a partially deployed second position within theoccluder device 80, wherein theoccluder device 80 remains inside theouter sheath 56. Theshaft 78 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66. Thesecond half 76 of theanchor 72 remains in the deployed second position within thepericardial space 68, wherein thefirst half 74 of theanchor 72 is in the partially deployed second position within theoccluder device 80. Alternatively, theanchor 72 andoccluder device 80 may be integral, wherein theoccluder device 80 may be a coil occluder device. Thus, theintegral anchor 72 andoccluder device 80 may be advanced together through theanchor catheter 58, wherein theanchor 72 is implanted in theLAA wall 66 using thesystem 50 of the present invention described above. - Illustrated in
FIG. 16 , theouter sheath 56 may be retracted to allow theoccluder device 80 to expand inside theLAA 64. Moreover, retracting theouter sheath 56 allows thefirst half 74 of theanchor 72 to fully expand into the deployed second position within theoccluder device 80. Thus, theshaft 78 of theanchor 72 may extend through the hole in the distal end of theoccluder device 80, wherein the distal end of theoccluder device 80 pinches down on theshaft 78. Furthermore, the first half of theanchor 74 in the deployed second position may pin theoccluder device 80 against theLAA wall 66, wherein theanchor 72 effectively moors theoccluder device 80 inside theLAA 64. At this time the expandedanchor 72 in the deployed second position covers a large surface area and therefore retains theoccluder device 80 in an implanted position within theLAA 64. Moreover, by anchoring theoccluder device 80 via theanchor 72 through all three layers of theLAA wall 66—instead of merely latching onto the thin endocardium layer—theanchoring system 50 of the present invention lowers the risk of embolization. Here, theanchor cable 82 remains attached to theanchor 72 and theoccluder cable 84 remains attached to theoccluder device 80 in case problems arise after deployment of theoccluder device 80. If no problems arise and it is determined that theoccluder device 80 is in an optimal location of theLAA 64, theoccluder cable 84 may be detached from theoccluder device 80 and removed from theLAA 64. Furthermore, theanchor cable 82 may be detached from theanchor 72 and removed from theLAA 64. Thebuddy wire 62 anddelivery wire 60 may also be withdrawn from theLAA 64, leaving theoccluder device 80 anchored securely in theLAA 64 by the anchoringsystem 50 of the present invention. -
FIG. 17 illustrates theanchoring system 50 of the present invention if problems arise after deployment of theoccluder device 80. For instance, it may be determined that theoccluder device 80 is not placed in an optimal location of theLAA 64 after deployment to achieve maximum occlusion. In this situation—prior to release of theoccluder cable 84 from theoccluder device 80 and theanchor cable 82 from theanchor 72—theouter sheath 56 may be advanced over theoccluder device 80 to theLAA wall 66, wherein theoccluder device 80 is retracted inside theouter sheath 56 using theoccluder cable 82. Theanchor catheter 58 may then be advanced to theLAA wall 66, wherein thefirst half 74 of theanchor 72 is retracted inside theanchor catheter 58 using theanchor cable 82. Thus, using theanchor cable 82, thefirst half 74 of theanchor 72 retracts from the deployed second position to the contracted first position to fit inside theanchor catheter 58. Theouter sheath 56 containing theoccluder device 80 may then be removed from theLAA 64, or theoccluder device 80 may be re-deployed in a more optimal location of theLAA 64. If theoccluder device 80 is removed from theLAA 64, theanchor catheter 58 may be retrieved thereafter, allowing thefirst half 74 of theanchor 72 to expand from the contracted first position to the deployed second position within theLAA 64. Thus, the deployedanchor 72 remains inside theLAA 64 and allows for occlusion of thesmall hole 70 that was created by thepericardial catheter 54 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66. - Illustrated in
FIG. 18 , if optimal placement of theoccluder device 80 was not achieved theanchor 72 may be released from theanchor cable 82 and deployed alone within theLAA wall 66 to plug thesmall hole 70 and prevent fluids from entering thepericardial space 68. Thedelivery wire 60 andbuddy wire 62 may be subsequently removed from theLAA 64. This allows for anew anchor 72 to be placed within theLAA wall 66 using theanchoring system 50 cited above for achieving optimal placement of theoccluder device 80 within theLAA 64. On the other hand, if theanchor 72 is initially placed in an optimal location within theLAA wall 66 but there are problems with theoccluder device 80, a second occluder device may be advanced over theinner sheath 58 and deployed within theLAA 64 using theanchoring system 50 cited above. Thus, the anchoringsystem 50 of the present invention allows an interventional cardiologist to quickly and cost-effectively implant theoccluder device 80 into theLAA 64 usinganchor 72, safely retrieve or re-deploy theoccluder device 80 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of theLAA 24. After optimal placement of theoccluder device 80 within theLAA 64 is achieved, thedelivery wire 60 andbuddy wire 62 may be removed from theLAA 64. - In another aspect of the present invention, an
anchor 72 is provided for anchoring anoccluder device 80 within aLAA 64. As illustrated inFIG. 13 , theanchor 72 may be shaped like a sheave, comprising afirst half 74, asecond half 76, and ashaft 78 connecting thefirst half 74 to thesecond half 76, although it is contemplated that other anchor shapes may also be utilized in the present invention. Theanchor 72 may be comprised of wire, wherein thefirst half 74 andsecond half 76 of theanchor 72 comprise wire mesh, further wherein theshaft 78 may comprise a single wire connecting the first half 75 wire mesh and thesecond half 76 wire mesh. Theanchor 72 may further be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape, and may be comprised of single or multiple wires. Theanchor 72 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. Theanchor 72 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 72 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. Theanchor 72 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. - Illustrated in
FIGS. 13A-B , theanchor 72 may have a contracted first position (FIG. 13A ) and a deployed second position (FIG. 13B ). In the contracted first position (FIG. 13A ), thefirst half 74,second half 76, andshaft 78 of theanchor 72 have a diameter of approximately 1-5 mm and a length of approximately 5-55 mm. In the deployed second position (FIG. 13B ), thefirst half 74 andsecond half 76 of theanchor 72 may expand outwards a distance of approximately 5-25 mm in diameter, wherein theshaft 78 remains approximately 1-5 mm in diameter. Theanchor 72 may self-expand from the contracted first position (FIG. 13A ) to the deployed second position (FIG. 13B ). - It is contemplated that the
anchor 72 of the present invention may be used with a diverse range ofLAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples ofoccluder devices 80 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. In the present invention, theoccluder device 80 may have a distal end with a hole approximately 1-5 mm in diameter. - Illustrated in
FIG. 14 , theanchor 72 in the contracted first position (FIG. 13A ) may be advanced through ananchor catheter 58 using ananchor cable 82 and adelivery wire 60, wherein theanchor 72 extends intopericardial space 68. Theanchor catheter 58 may then be retracted, allowing thesecond half 76 of theanchor 72 to self-expand from the contracted first position to the deployed second position within thepericardial space 68. While thesecond half 76 of theanchor 72 is in the deployed second position, theshaft 72 and thefirst half 74 of theanchor 72 remain temporarily inside theanchor catheter 58. - Illustrated in
FIG. 15 , theanchor catheter 58 may be further retracted, allowing thefirst half 74 of theanchor 72 to self-expand from the contracted first position to a partially deployed second position within theoccluder device 80, wherein theoccluder device 80 remains inside theouter sheath 56. Theshaft 78 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26. Thesecond half 76 of theanchor 72 remains in the deployed second position within thepericardial space 68, wherein thefirst half 74 of theanchor 72 is in the partially deployed second position within theoccluder device 80. Alternatively, theanchor 72 andoccluder device 80 may be integral, wherein theoccluder device 80 may be a coil occluder device. Thus, theintegral anchor 72 andoccluder device 80 may be advanced together through theanchor catheter 58, wherein theanchor 72 is implanted in theLAA wall 26 using thesystem 50 of the present invention described above. - Illustrated in
FIG. 16 , theouter sheath 56 may be retracted to allow theoccluder device 80 to expand inside theLAA 64. Moreover, retracting theouter sheath 56 allows thefirst half 74 of theanchor 72 to fully expand into the deployed second position within theoccluder device 80. Thus, theshaft 78 of theanchor 72 may extend through the hole in the distal end of theoccluder device 80, wherein the distal end of theoccluder device 80 pinches down on theshaft 78. Furthermore, the first half of theanchor 74 in the deployed second position may pin theoccluder device 80 against theLAA wall 66, wherein theanchor 72 effectively moors theoccluder device 80 inside theLAA 64. At this time the expandedanchor 72 in the deployed second position covers a large surface area and therefore retains theoccluder device 80 in an implanted position within theLAA 64. Moreover, by anchoring theoccluder device 80 via theanchor 72 through all three layers of theLAA wall 66—instead of merely latching onto the thin endocardium layer—theanchoring system 50 of the present invention lowers the risk of embolization. Here, theanchor cable 82 remains attached to theanchor 72 and anoccluder cable 84 remains attached to theoccluder device 80 in case problems arise after deployment of theoccluder device 80. If no problems arise and it is determined that theoccluder device 80 is in an optimal location of theLAA 64, theoccluder cable 84 may be detached from theoccluder device 80 and removed from theLAA 64. Furthermore, theanchor cable 82 may be detached from theanchor 72 and removed from theLAA 64. Thedelivery wire 60 and/or abuddy wire 62 may also be withdrawn from theLAA 64, leaving theoccluder device 80 anchored securely in theLAA 64 by theanchor 72 of the present invention. - In yet another aspect of the present invention, a method of implanting and retrieving an occluder device within a LAA is illustrated in
FIG. 10 . The method of the present invention comprises providing ananchoring system 50. The anchoringsystem 50 may comprise apericardial catheter 54, wherein thepericardial catheter 54 may be a single or double-lumen pericardial catheter. The anchoringsystem 50 may further comprise anouter sheath 56. A balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized. Thepericardial catheter 54 may be configured to fit adelivery wire 60 and/or abuddy wire 62, also standardly used in the industry. A diameter of thedelivery wire 60 may range between approximately 0.025-0.052 inches and a diameter of thebuddy wire 62 may range between approximately 0.008-0.025 inches. - Further illustrated in
FIG. 10 , the method of the present invention further comprises inserting theouter sheath 56 into theLAA 64 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude theLAA 64 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of theouter sheath 56 within theLAA 64 and allow for better imaging of theLAA 64 by an interventional cardiologist. Thepericardial catheter 54 may be advanced through theouter sheath 56 to theLAA wall 66. Thebuddy wire 62 is next advanced through thepericardial catheter 54 and theadjacent LAA wall 66, wherein thebuddy wire 62 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 26 to extend into thepericardial space 68. Thepericardial catheter 54 is advanced over thebuddy wire 62 and through theLAA wall 66, penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66 to extend into thepericardial space 68. Thus, thepericardial catheter 54 creates asmall hole 70 through theLAA wall 66 of the heart. If utilized, the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within thepericardial space 68 via thesmall hole 70. While thepericardial catheter 54 remains inside thepericardial space 68 via thesmall hole 70, thedelivery wire 60 may then be advanced through thepericardial catheter 54, wherein thedelivery wire 60 enters thepericardial space 68. Thepericardial catheter 54 may then be removed from theouter sheath 56, leaving thedelivery wire 60 and thebuddy wire 62 inside thepericardial space 68 via thesmall hole 70 in theLAA wall 66. - Illustrated in
FIG. 11 , the method of the present invention further comprises providing ananchor catheter 58 and an inner dilator 86, wherein the inner dilator 86 includes a pointeddistal end 88. The inner dilator 86 may be configured to encompass thedelivery wire 60, wherein thedelivery wire 60 may traverse through an inner lumen of the inner dilator 86. Theanchor catheter 58 and the inner dilator 86 may be advanced through theouter sheath 56 to theLAA wall 66 adjacent thesmall hole 70. Particularly, thedelivery wire 60 may traverse through the anchor catheter 52 and the inner dilator 86. Thebuddy wire 62 may reside outside theanchor catheter 58 and yet inside theouter sheath 56. Using the pointeddistal end 88 of the inner dilator 86, the inner dilator 86 and the anchor catheter 52 may be further advanced through thesmall hole 70 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66. Thus, the pointeddistal end 88 of the inner dilator 86, along with a distal end of the anchor catheter 52, extends into thepericardial space 68. The inner dilator 86 may be subsequently removed from theanchor catheter 58, wherein the distal end of theanchor catheter 58 remains extending into thepericardial space 68. - Illustrated in
FIG. 12 , the method of the present invention further comprises providing anoccluder device 80 and anoccluder cable 84. It is contemplated that the method of the present invention may be used with a diverse range ofLAA occluder devices 80 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples ofoccluder devices 80 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. In the present invention, theoccluder device 80 may have a distal end with a hole approximately 1-5 mm in diameter. As shown inFIG. 12 , theoccluder cable 84 may be a hollow coaxial cable standardly used in the industry. Theoccluder cable 84 may be attached to theoccluder device 80, wherein theoccluder cable 84 may be used for deploying and retrieving theoccluder device 80 within theLAA 64. Theoccluder device 80 and theoccluder cable 84 may encompass theanchor catheter 58, wherein theanchor catheter 58 may traverse through an inner lumen of theoccluder device 80 and an inner lumen of theoccluder cable 84. Theoccluder device 80 may reside between theanchor catheter 58 and theouter sheath 56. - As further shown in
FIG. 12 , the method of the present invention further comprises providing ananchor 72 and ananchor cable 82, wherein theanchor 72 andanchor cable 82 are inserted in theanchor catheter 58. Theanchor cable 82 may be attached to theanchor 72, wherein theanchor cable 82 may be used for deploying theanchor 72 within theLAA wall 66. Theanchor cable 82 may be a hollow coaxial cable standardly used in the industry. Theanchor cable 82 andanchor 72 may encompass thedelivery wire 60, wherein thedelivery wire 60 may traverse through an inner lumen of theanchor 72 and an inner lumen of theanchor cable 82. Thedelivery wire 60 may be used to navigate theanchoring system 50 through theLAA 64. Alternatively, theanchor 72 andanchor cable 82 may be advanced through theanchor catheter 58 into thepericardial space 68 without using thedelivery wire 60. Thebuddy wire 62 may remain inside thepericardial space 68 and is a safety feature in case of emergencies. Thebuddy wire 62 allows an interventional cardiologist to advance another catheter through theLAA wall 66 and place a plug within thesmall hole 70 if a malfunction is observed with theanchor 72 or theoccluder device 80. - Illustrated in
FIG. 13 , theanchor 72 may be shaped like a sheave, comprising afirst half 74, asecond half 76, and ashaft 78 connecting thefirst half 74 to thesecond half 76, although it is contemplated that other anchor shapes may also be utilized in the present invention. Theanchor 72 may be comprised of wire, wherein thefirst half 74 andsecond half 76 of theanchor 72 comprise wire mesh, further wherein theshaft 78 may comprise a single wire connecting the first half 75 wire mesh and thesecond half 76 wire mesh. Theanchor 72 may be comprised of a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape, and may be comprised of single or multiple wires. Theanchor 72 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. Theanchor 72 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 72 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. Theanchor 72 may have a lumen wherein thedelivery wire 60 traverses therein, alternatively, theanchor 72 may not have a lumen. Theanchor 72 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. - Illustrated in
FIGS. 13A-B , theanchor 72 may have a contracted first position (FIG. 13A ) and a deployed second position (FIG. 13B ). In the contracted first position (FIG. 13A ), thefirst half 74,second half 76, andshaft 78 of theanchor 72 have a diameter of approximately 1-5 mm and a length of approximately 5-55 mm. In the deployed second position (FIG. 13B ), thefirst half 74 andsecond half 76 of theanchor 72 may expand outwards a distance of approximately 5-25 mm in diameter, wherein theshaft 78 remains approximately 1-5 mm in diameter. Theanchor 72 may self-expand from the contracted first position (FIG. 13A ) to the deployed second position (FIG. 13B ). - Illustrated in
FIG. 14 , the method of the present invention comprises advancing theanchor 72 in the contracted first position (FIG. 13A ) through theanchor catheter 58 using theanchor cable 82 and thedelivery wire 60, wherein theanchor 72 extends into thepericardial space 68. Theanchor catheter 58 may then be retracted, allowing thesecond half 76 of theanchor 72 to self-expand from the contracted first position to the deployed second position within thepericardial space 68. While thesecond half 76 of theanchor 72 is in the deployed second position, theshaft 78 and thefirst half 74 of theanchor 72 remain temporarily inside theanchor catheter 58. - Illustrated in
FIG. 15 , the method of the present invention further comprises retracting theanchor catheter 58, allowing thefirst half 74 of theanchor 72 to self-expand from the contracted first position to a partially deployed second position within theoccluder device 80, wherein theoccluder device 80 remains inside theouter sheath 56. Theshaft 78 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66. Thesecond half 76 of theanchor 72 remains in the deployed second position within thepericardial space 68, wherein thefirst half 74 of theanchor 72 is in the partially deployed second position within theoccluder device 80. Alternatively, theanchor 72 andoccluder device 80 may be integral, wherein theoccluder device 80 may be a coil occluder device. Thus, theintegral anchor 72 andoccluder device 80 may be advanced together through theanchor catheter 58, wherein theanchor 72 is implanted in theLAA wall 66 using thesystem 50 of the present invention described above. - Illustrated in
FIG. 16 , the method of the present invention comprises retracting theouter sheath 56 to allow theoccluder device 80 to expand inside theLAA 64. Moreover, retracting theouter sheath 56 allows thefirst half 74 of theanchor 72 to fully expand into the deployed second position within theoccluder device 80. Thus, theshaft 78 of theanchor 72 may extend through the hole in the distal end of theoccluder device 80, wherein the distal end of theoccluder device 80 pinches down on theshaft 78. Furthermore, the first half of theanchor 74 in the deployed second position may pin theoccluder device 80 against theLAA wall 66, wherein theanchor 72 effectively moors theoccluder device 80 inside theLAA 64. At this time the expandedanchor 72 in the deployed second position covers a large surface area and therefore retains theoccluder device 80 in an implanted position within theLAA 64. Moreover, by anchoring theoccluder device 80 via theanchor 72 through all three layers of theLAA wall 66—instead of merely latching onto the thin endocardium layer—the method of the present invention lowers the risk of embolization. Here, theanchor cable 82 remains attached to theanchor 72 and theoccluder cable 84 remains attached to theoccluder device 80 in case problems arise after deployment of theoccluder device 80. If no problems arise and it is determined that theoccluder device 80 is in an optimal location of theLAA 64, theoccluder cable 84 may be detached from theoccluder device 80 and removed from theLAA 64. Furthermore, theanchor cable 82 may be detached from theanchor 72 and removed from theLAA 64. Thebuddy wire 62 anddelivery wire 60 may also be withdrawn from theLAA 64, leaving theoccluder device 80 anchored securely in theLAA 64 by the method of the present invention. -
FIG. 17 illustrates the method of the present invention if problems arise after deployment of theoccluder device 80. For instance, the method comprises making a determination that theoccluder device 80 is not placed in an optimal location of theLAA 64 after deployment to achieve maximum occlusion. In this situation—prior to release of theoccluder cable 84 from theoccluder device 80 and theanchor cable 82 from theanchor 72—theouter sheath 56 may be advanced over theoccluder device 80 to theLAA wall 66, wherein theoccluder device 80 is retracted inside theouter sheath 56 using theoccluder cable 82. Theanchor catheter 58 may then be advanced to theLAA wall 66, wherein thefirst half 74 of theanchor 72 is retracted inside theanchor catheter 58 using theanchor cable 82. Thus, using theanchor cable 82, thefirst half 74 of theanchor 72 retracts from the deployed second position to the contracted first position to fit inside theanchor catheter 58. Theouter sheath 56 containing theoccluder device 80 may then be removed from theLAA 64, or theoccluder device 80 may be re-deployed in a more optimal location of theLAA 64. If theoccluder device 80 is removed from theLAA 64, theanchor catheter 58 may be retrieved thereafter, allowing thefirst half 74 of theanchor 72 to expand from the contracted first position to the deployed second position within theLAA 64. Thus, the deployedanchor 72 remains inside theLAA 64 and allows for occlusion of thesmall hole 70 that was created by thepericardial catheter 54 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 66. - Illustrated in
FIG. 18 , if a determination is made that optimal placement of theanchor 72 was not achieved, theanchor 72 may be released from theanchor cable 82 and deployed alone within theLAA wall 66 to plug thesmall hole 70 and prevent fluids from entering thepericardial space 68. Thedelivery wire 60 andbuddy wire 62 may be subsequently removed from theLAA 64. This allows for anew anchor 72 to be placed within theLAA wall 66 using the method cited above for achieving optimal placement of theoccluder device 80 within theLAA 64. On the other hand, if a determination is made that theanchor 72 is initially placed in an optimal location within theLAA wall 66 but there are problems with theoccluder device 80, a second occluder device may be advanced over theinner sheath 58 and deployed within theLAA 64 using the method cited above. Thus, the method of the present invention allows an interventional cardiologist to quickly and cost-effectively implant theoccluder device 80 into theLAA 64 usinganchor 72, safely retrieve or re-deploy theoccluder device 80 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of theLAA 24. After optimal placement of theoccluder device 80 within theLAA 64 is achieved, thedelivery wire 60 andbuddy wire 62 may be removed from theLAA 64. -
FIG. 19 illustrates yet a further aspect of the present invention, ananchoring system 90 for implanting and retrieving an occluder device within a LAA. The anchoringsystem 90 may comprise apericardial catheter 94, wherein thepericardial catheter 94 may be a single or double-lumen pericardial catheter. The anchoringsystem 90 may further comprise anouter sheath 96 and aninner sheath 98. A balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized. Thepericardial catheter 94 may be configured to fit adelivery wire 100 and/or abuddy wire 102, also standardly used in the industry. A diameter of thedelivery wire 100 may range between approximately 0.025-0.052 inches and a diameter of thebuddy wire 102 may range between approximately 0.008-0.025 inches. - Further shown in
FIG. 19 , theouter sheath 96 may be inserted intoLAA 104 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure to aLAA wall 106. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude theLAA 104 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of theouter sheath 96 within theLAA 104 and allow for better imaging of theLAA 104 by an interventional cardiologist. Thepericardial catheter 94 may be advanced through theouter sheath 96 to theLAA wall 106. Thebuddy wire 102 is next advanced through thepericardial catheter 94 and theadjacent LAA wall 106, wherein thebuddy wire 102 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend into thepericardial space 108. Thepericardial catheter 94 is next advanced over thebuddy wire 104 and through theLAA wall 106, penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend into thepericardial space 108. Thus, thepericardial catheter 94 creates asmall hole 110 through theLAA wall 106 of the heart. If utilized, the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within thepericardial space 108 via thesmall hole 110. While thepericardial catheter 94 remains inside thepericardial space 108 via thesmall hole 110, thedelivery wire 100 may then be advanced through thepericardial catheter 94, wherein thedelivery wire 100 enters thepericardial space 108. Thepericardial catheter 94 may then be removed from theouter sheath 96, leaving thedelivery wire 100 and thebuddy wire 102 inside thepericardial space 108 via thesmall hole 110 in theLAA wall 106. - Illustrated in
FIG. 20 , the anchoringsystem 90 of the present invention further comprises anoccluder device 120 and anoccluder cable 124. It is contemplated that theanchoring system 90 of the present invention may be used with a diverse range ofLAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples ofoccluder devices 120 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. In the present invention, theoccluder device 120 may have a distal end with a hole approximately 1-5 mm in diameter. - As shown in
FIG. 20 , theoccluder cable 124 may be a hollow coaxial cable standardly used in the industry. Theoccluder cable 124 may be attached to theoccluder device 120, wherein theoccluder cable 124 may be used for deploying and retrieving theoccluder device 120 within theLAA 104. Theoccluder device 120 and theoccluder cable 124 may encompass theinner sheath 98, wherein theinner sheath 98 may traverse through an inner lumen of theoccluder device 120 and an inner lumen of theoccluder cable 124. Theoccluder device 120 may reside between theinner sheath 98 and theouter sheath 96. - As further shown in
FIG. 20 , theinner sheath 98 may be advanced through theouter sheath 96 to theLAA wall 106 adjacent thesmall hole 110. Particularly, thedelivery wire 100 may traverse through theinner sheath 98, theoccluder device 120, and theoccluder cable 124. Thebuddy wire 102 may reside outside theinner sheath 98 and yet inside theouter sheath 96. - As also shown in
FIG. 20 , theinner sheath 98 may comprise ananchor 112 and ananchor cable 122. Theanchor cable 122 may be attached to theanchor 112, wherein theanchor cable 122 may be used for deploying theanchor 112 within theLAA wall 106. Theanchor cable 122 may be a hollow coaxial cable standardly used in the industry. Theanchor cable 122 andanchor 112 may encompass thedelivery wire 100, wherein thedelivery wire 100 may traverse through an inner lumen of theanchor 112 and an inner lumen of theanchor cable 122. Thedelivery wire 100 may be used to navigate theanchoring system 90 through theLAA 104. Alternatively, theanchor 112 andanchor cable 122 may be advanced through theinner sheath 98 into thepericardial space 108 without using thedelivery wire 100. Thebuddy wire 102 may remain inside thepericardial space 108 and is a safety feature in case of emergencies. Thebuddy wire 102 allows an interventional cardiologist to advance another catheter through theLAA wall 106 and place a plug within thesmall hole 110 if a malfunction is observed with theanchor 112 or theoccluder device 120. - Illustrated in
FIGS. 21A and 21B , theanchor 112 may have an elongate contracted first position (FIG. 21A ) (e.g., straight—coil) when thedelivery wire 100 is traversing the inner lumen of theanchor 112, and a deployed second position (FIG. 21B ) (e.g., double-coil) when thedelivery wire 100 has been removed from the inner lumen of theanchor 112. Thedelivery wire 100 when inside the inner lumen of theanchor 112 straightens theanchor 112 from its natural coiled state (deployed second position) into the elongated straight-coil (contracted first position). In the contracted first position (FIG. 21A ), theanchor 112 has a diameter of approximately 0.5-2 mm and a length of approximately 2-40 mm. In the deployed second position (FIG. 21B ), theanchor 112 may comprise afirst coil 114, asecond coil 116, wherein thefirst coil 114 andsecond coil 116 are connected together by ashaft 118. In the deployed second position (FIG. 21B ), thefirst coil 114 andsecond coil 116 expand outwards a distance of approximately 5-15 mm in diameter, theshaft 118 remains approximately 0.5-2 mm in diameter, wherein the total length of theanchor 112 is approximately 1-10 mm. Theanchor 112 may self-expand from the contracted first position (FIG. 21A ) to the deployed second position (FIG. 21B ). - Illustrated in
FIG. 21B , thefirst coil 114 andsecond coil 116 of theanchor 112 may be shaped like circular disks, although it is contemplated that other anchor shapes may also be utilized in the present invention. For instance, the anchor coils 114, 116 may comprise a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape. Theanchor 112 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. Theanchor 112 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 112 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. Theanchor 112 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. - Illustrated in
FIG. 22 , theanchor 112 in the contracted first position (FIG. 21A ) may be advanced through theinner sheath 98 using theanchor cable 122 and thedelivery wire 100, wherein theanchor 112 is further advanced through thesmall hole 110 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend into thepericardial space 68. Thedelivery wire 100 may then be retracted, allowing thesecond coil 116 of theanchor 112 to self-expand from the contracted first position to the deployed second position within thepericardial space 108. While thesecond coil 116 of theanchor 112 is in the deployed second position, theshaft 118 and thefirst coil 114 of theanchor 112 remain temporarily in the contracted first position. - Illustrated in
FIG. 23 , theinner sheath 98 adjacent theLAA wall 106 may be retracted along with thedelivery wire 100, allowing thefirst coil 114 of theanchor 112 to self-expand from the contracted first position to a partially deployed second position within theoccluder device 120. Theoccluder device 120 remains inside theouter sheath 96 adjacent theLAA wall 106. Theshaft 118 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106. Thesecond coil 116 of theanchor 112 remains in the deployed second position within thepericardial space 108, wherein thefirst coil 114 of theanchor 112 is in the partially deployed second position within theoccluder device 120. Alternatively, theanchor 112 andoccluder device 120 may be integral, wherein theoccluder device 120 may be a coil occluder device. Thus, theintegral anchor 112 andoccluder device 120 may be advanced together through theinner sheath 98, wherein theanchor 112 is implanted in theLAA wall 106 using thesystem 90 of the present invention described above. - Illustrated in
FIG. 24 , theouter sheath 96 may be retracted to allow theoccluder device 120 to expand inside theLAA 104. Moreover, retracting theouter sheath 96 allows thefirst coil 114 of theanchor 112 to fully expand into the deployed second position within theoccluder device 120. Thus, theshaft 118 of theanchor 112 may extend through the hole in the distal end of theoccluder device 120, wherein the distal end of theoccluder device 120 pinches down on theshaft 118. Furthermore, thefirst coil 114 of theanchor 112 in the deployed second position may pin theoccluder device 120 against theLAA wall 106, wherein theanchor 112 effectively moors theoccluder device 120 inside theLAA 104. At this time the expandedanchor 112 in the deployed second position covers a large surface area and therefore retains theoccluder device 120 in an implanted position within theLAA 104. Moreover, by anchoring theoccluder device 120 via theanchor 112 through all three layers of theLAA wall 106—instead of merely latching onto the thin endocardium layer—theanchoring system 90 of the present invention lowers the risk of embolization. Thesecond coil 116 located within thepericardial space 108 may unwind in a clockwise fashion, while thefirst coil 114 located in theLAA 104 may unwind in an reverse-clockwise fashion. Thus, there would be counter-forces acting on the coils, wherein thesecond coil 116 exerts proximal traction and thefirst coil 114 exerts distal traction against opposite sides of theLAA wall 106. Such counter-forces discourage theanchor 112 from unraveling while in the deployed second position within theLAA wall 106. - The
anchor cable 122 remains attached to theanchor 112 and theoccluder cable 124 remains attached to theoccluder device 120 in case problems arise after deployment of theoccluder device 120. If no problems arise and it is determined that theoccluder device 120 is in an optimal location of theLAA 104, theoccluder cable 124 may be detached from theoccluder device 120 and removed from theLAA 104. Furthermore, theanchor cable 122 may be detached from theanchor 112 and removed from theLAA 104. Thebuddy wire 102 anddelivery wire 100 may also be withdrawn from theLAA 106, leaving theoccluder device 120 anchored securely in theLAA 104 by the anchoringsystem 90 of the present invention. -
FIG. 25 illustrates theanchoring system 90 of the present invention if problems arise after deployment of theoccluder device 120. For instance, it may be determined that theoccluder device 120 is not placed in an optimal location of theLAA 104 after deployment to achieve maximum occlusion. In this situation—prior to release of theoccluder cable 124 from theoccluder device 120 and theanchor cable 122 from theanchor 112—theouter sheath 96 may be advanced over theoccluder device 120, wherein theoccluder device 120 is retracted inside theouter sheath 96 using theoccluder cable 124. Thedelivery wire 100 may be further advanced through theanchor cable 112 andfirst coil 114 of theanchor 112, wherein thefirst coil 114 retracts from the deployed second position to the contracted first position and may be retrieved inside theinner sheath 98. Theouter sheath 96 containing theoccluder device 120 may then be removed from theLAA 104, or theoccluder device 120 may be re-deployed in a more optimal location of theLAA 104. If theoccluder device 120 is removed from theLAA 104, thedelivery wire 100 may be retrieved thereafter, allowing thefirst coil 114 of theanchor 112 to re-expand from the contracted first position to the deployed second position within theLAA 104. Thus, the deployedanchor 112 remains inside theLAA 104 and allows for occlusion of thesmall hole 110 that was created by thepericardial catheter 94 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106. - Illustrated in
FIG. 26 , if optimal placement of theoccluder device 120 was not achieved theanchor 112 may be released from theanchor cable 122 and deployed alone within theLAA wall 106. This allows for anew anchor 112 to be placed within theLAA wall 106 using theanchoring system 90 cited above for achieving optimal placement of theoccluder device 120 within theLAA 104. On the other hand, if theanchor 112 is initially placed in an optimal location within theLAA wall 106 but there are problems with theoccluder device 120, a second occluder device may be advanced using theinner sheath 98 and deployed within theLAA 104 using theanchoring system 90 cited above. Thus, the anchoringsystem 90 of the present invention allows an interventional cardiologist to quickly and cost-effectively implant theoccluder device 120 into theLAA 104 usinganchor 112, safely retrieve or re-deploy theoccluder device 120 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of theLAA 104. After optimal placement of theoccluder device 120 within theLAA 104 is achieved, thedelivery wire 100 and thebuddy wire 102 may be removed from theLAA 104. - In another aspect of the present invention, an
anchor 112 is provided for anchoring anoccluder device 120 within aLAA 104. As illustrated inFIGS. 21A and 21B , theanchor 112 may have an elongate contracted first position (FIG. 21A ) (e.g., straight—coil) when adelivery wire 100 is traversing an inner lumen of theanchor 112, and a deployed second position (FIG. 21B ) (e.g., double-coil) when thedelivery wire 100 has been removed from the inner lumen of theanchor 112. Thedelivery wire 100 when inside the inner lumen of theanchor 112 straightens theanchor 112 from its natural coiled state (deployed second position) into the elongated straight-coil (contracted first position). In the contracted first position (FIG. 21A ), theanchor 112 has a diameter of approximately 0.5-2 mm and a length of approximately 2-40 mm. In the deployed second position (FIG. 21B ), theanchor 112 may comprise afirst coil 114, asecond coil 116, wherein thefirst coil 114 andsecond coil 116 are connected together by ashaft 118. In the deployed second position (FIG. 21B ), thefirst coil 114 andsecond coil 116 expand outwards a distance of approximately 5-15 mm in diameter, theshaft 118 remains approximately 0.5-2 mm in diameter, wherein the total length of theanchor 112 is approximately 1-10 mm. Theanchor 112 may self-expand from the contracted first position (FIG. 21A ) to the deployed second position (FIG. 21B ). - Illustrated in
FIG. 21B , thefirst coil 114 andsecond coil 116 of theanchor 112 may be shaped like circular disks, although it is contemplated that other anchor shapes may also be utilized in the present invention. For instance, the anchor coils 114, 116 may comprise a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape. Theanchor 112 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. Theanchor 112 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 112 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. Theanchor 112 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. - It is contemplated that the
anchor 112 of the present invention may be used with a diverse range ofLAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples ofoccluder devices 120 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. In the present invention, theoccluder device 120 may have a distal end with a hole approximately 1-5 mm in diameter. - Illustrated in
FIG. 22 , theanchor 112 in the contracted first position (FIG. 21A ) may be advanced through aninner sheath 98 using ananchor cable 122 and thedelivery wire 100, wherein theanchor 112 is further advanced through asmall hole 110 in anLAA wall 106 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend intopericardial space 68. Thedelivery wire 100 may then be retracted, allowing thesecond coil 116 of theanchor 112 to self-expand from the contracted first position to the deployed second position within thepericardial space 108. While thesecond coil 116 of theanchor 112 is in the deployed second position, theshaft 118 and thefirst coil 114 of theanchor 112 remain temporarily in the contracted first position. - Illustrated in
FIG. 23 , theinner sheath 98 adjacent theLAA wall 106 may be retracted along with thedelivery wire 100, allowing thefirst coil 114 of theanchor 112 to self-expand from the contracted first position to a partially deployed second position within theoccluder device 120. Theoccluder device 120 remains inside anouter sheath 96 adjacent theLAA wall 106. Theshaft 118 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106. Thesecond coil 116 of theanchor 112 remains in the deployed second position within thepericardial space 108, wherein thefirst coil 114 of theanchor 112 is in the partially deployed second position within theoccluder device 120. Alternatively, theanchor 112 andoccluder device 120 may be integral, wherein theoccluder device 120 may be a coil occluder device. Thus, theintegral anchor 112 andoccluder device 120 may be advanced together through theinner sheath 98, wherein theanchor 112 is implanted in theLAA wall 106 using thesystem 90 of the present invention described above. - Illustrated in
FIG. 24 , theouter sheath 96 may be retracted to allow theoccluder device 120 to expand inside theLAA 104. Moreover, retracting theouter sheath 96 allows thefirst coil 114 of theanchor 112 to fully expand into the deployed second position within theoccluder device 120. Thus, theshaft 118 of theanchor 112 may extend through the hole in the distal end of theoccluder device 120, wherein the distal end of theoccluder device 120 pinches down on theshaft 118. Furthermore, thefirst coil 114 of theanchor 112 in the deployed second position may pin theoccluder device 120 against theLAA wall 106, wherein theanchor 112 effectively moors theoccluder device 120 inside theLAA 104. At this time the expandedanchor 112 in the deployed second position covers a large surface area and therefore retains theoccluder device 120 in an implanted position within theLAA 104. Moreover, by anchoring theoccluder device 120 via theanchor 112 through all three layers of theLAA wall 106—instead of merely latching onto the thin endocardium layer—theanchoring system 90 of the present invention lowers the risk of embolization. Thesecond coil 116 located within thepericardial space 108 may unwind in a clockwise fashion, while thefirst coil 114 located in theLAA 104 may unwind in an reverse-clockwise fashion. Thus, there would be counter-forces acting on the coils, wherein thesecond coil 116 exerts proximal traction and thefirst coil 114 exerts distal traction against opposite sides of theLAA wall 106. Such counter-forces discourage theanchor 112 from unraveling while in the deployed second position within theLAA wall 106. - The
anchor cable 122 remains attached to theanchor 112 and anoccluder cable 124 remains attached to theoccluder device 120 in case problems arise after deployment of theoccluder device 120. If no problems arise and it is determined that theoccluder device 120 is in an optimal location of theLAA 104, theoccluder cable 124 may be detached from theoccluder device 120 and removed from theLAA 104. Furthermore, theanchor cable 122 may be detached from theanchor 112 and removed from theLAA 104. Thedelivery wire 100 and/or abuddy wire 102 may also be withdrawn from theLAA 106, leaving theoccluder device 120 anchored securely in theLAA 104 by the anchoringsystem 90 of the present invention. - In yet another aspect of the present invention, a method of implanting and retrieving an occluder device within a LAA is illustrated in
FIG. 19 . The method of the present invention comprises providing ananchoring system 90. The anchoringsystem 90 may comprise apericardial catheter 94, wherein thepericardial catheter 94 may be a single or double-lumen pericardial catheter. The anchoringsystem 90 may further comprise anouter sheath 96 and aninner sheath 98. A balloon-occlusion catheter may also be utilized by the present invention. However, it is intended that other catheters standard in the industry may also be utilized. Thepericardial catheter 94 may be configured to fit adelivery wire 100 and/or abuddy wire 102, also standardly used in the industry. A diameter of thedelivery wire 100 may range between approximately 0.025-0.052 inches and a diameter of thebuddy wire 102 may range between approximately 0.008-0.025 inches. - Further shown in
FIG. 19 , the method of the present invention further comprises inserting theouter sheath 96 intoLAA 104 via the left atrium proper of the heart by crossing the atrial septum using a transeptal procedure to theLAA wall 106. If a balloon-occlusion catheter has been utilized, the balloon occlusion may be expanded to occlude theLAA 104 from the left atrium proper. Expanding the balloon occlusion may improve stabilization of theouter sheath 96 within theLAA 104 and allow for better imaging of theLAA 104 by an interventional cardiologist. Thepericardial catheter 94 may be advanced through theouter sheath 96 to theLAA wall 106. Thebuddy wire 102 is next advanced through thepericardial catheter 94 and theadjacent LAA wall 106, wherein thebuddy wire 102 penetrates the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend into thepericardial space 108. Thepericardial catheter 94 is next advanced over thebuddy wire 104 and through theLAA wall 106, penetrating the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend into thepericardial space 108. Thus, thepericardial catheter 94 creates asmall hole 110 through theLAA wall 106 of the heart. If utilized, the expanded balloon occlusion of the balloon-occlusion catheter decreases the likelihood of fluid accumulating within thepericardial space 108 via thesmall hole 110. While thepericardial catheter 94 remains inside thepericardial space 108 via thesmall hole 110, thedelivery wire 100 may then be advanced through thepericardial catheter 94, wherein thedelivery wire 100 enters thepericardial space 108. Thepericardial catheter 94 may then be removed from theouter sheath 96, leaving thedelivery wire 100 and thebuddy wire 102 inside thepericardial space 108 via thesmall hole 110 in theLAA wall 106. - Illustrated in
FIG. 20 , the method of the present invention further comprises providing anoccluder device 120 and anoccluder cable 124. It is contemplated that the method of the present invention may be used with a diverse range ofLAA occluder devices 120 such as coil implants, foam plugs, expandable frames, combinations thereof, and other occluder devices currently used in the industry and/or to be developed in the future. Specific examples ofoccluder devices 120 that may be used by the present invention include, but are not limited to, WATCHMAN®, ATRICLIP®, PLAATO LAA Occlusion System®, AMPLATZER™, and AMULET™. In the present invention, theoccluder device 120 may have a distal end with a hole approximately 1-5 mm in diameter. - As shown in
FIG. 20 , theoccluder cable 124 may be a hollow coaxial cable standardly used in the industry. Theoccluder cable 124 may be attached to theoccluder device 120, wherein theoccluder cable 124 may be used for deploying and retrieving theoccluder device 120 within theLAA 104. Theoccluder device 120 and theoccluder cable 124 may encompass theinner sheath 98, wherein theinner sheath 98 may traverse through an inner lumen of theoccluder device 120 and an inner lumen of theoccluder cable 124. Theoccluder device 120 may reside between theinner sheath 98 and theouter sheath 96. - As further shown in
FIG. 20 , the method of the present invention comprises advancing theinner sheath 98 through theouter sheath 96 to theLAA wall 106 adjacent thesmall hole 110. Particularly, thedelivery wire 100 may traverse through theinner sheath 98, theoccluder device 120, and theoccluder cable 124. Thebuddy wire 102 may reside outside theinner sheath 98 and yet inside theouter sheath 96. - Also shown in
FIG. 20 , the method of the present invention further comprises providing ananchor 112 and ananchor cable 122. Theanchor cable 122 may be attached to theanchor 112, wherein theanchor cable 122 may be used for deploying theanchor 112 within theLAA wall 106. Theanchor cable 122 may be a hollow coaxial cable standardly used in the industry. Theanchor cable 122 andanchor 112 may encompass thedelivery wire 100, wherein thedelivery wire 100 may traverse through an inner lumen of theanchor 112 and an inner lumen of theanchor cable 122. Thedelivery wire 100 may be used to navigate theanchoring system 90 through theLAA 104. Alternatively, theanchor 112 andanchor cable 122 may be advanced through theinner sheath 98 into thepericardial space 108 without using thedelivery wire 100. Thebuddy wire 102 may remain inside thepericardial space 108 and is a safety feature in case of emergencies. Thebuddy wire 102 allows an interventional cardiologist to advance another catheter through theLAA wall 106 and place a plug within thesmall hole 110 if a malfunction is observed with theanchor 112 or theoccluder device 120. - Illustrated in
FIGS. 21A and 21B , theanchor 112 may have an elongate contracted first position (FIG. 21A ) (e.g., straight—coil) when thedelivery wire 100 is traversing the inner lumen of theanchor 112, and a deployed second position (FIG. 21B ) (e.g., double-coil) when thedelivery wire 100 has been removed from the inner lumen of theanchor 112. Thedelivery wire 100 when inside the inner lumen of theanchor 112 straightens theanchor 112 from its natural coiled state (deployed second position) into the elongated straight-coil (contracted first position). In the contracted first position (FIG. 21A ), theanchor 112 has a diameter of approximately 0.5-2 mm and a length of approximately 2-40 mm. In the deployed second position (FIG. 21B ), theanchor 112 may comprise afirst coil 114, asecond coil 116, wherein thefirst coil 114 andsecond coil 116 are connected together by ashaft 118. In the deployed second position (FIG. 21B ), thefirst coil 114 andsecond coil 116 expand outwards a distance of approximately 5-15 mm in diameter, theshaft 118 remains approximately 0.5-2 mm in diameter, wherein the total length of theanchor 112 is approximately 1-10 mm. Theanchor 112 may self-expand from the contracted first position (FIG. 21A ) to the deployed second position (FIG. 21B ). - Illustrated in
FIG. 21B , thefirst coil 114 andsecond coil 116 of theanchor 112 may be shaped like circular disks, although it is contemplated that other anchor shapes may also be utilized in the method of the present invention. For instance, the anchor coils 114, 116 may comprise a square, rectangle, flat, sphere, circle, oval, pentagon, octagon, or any other shape. Theanchor 112 may be circular in diameter, however, it is contemplated that other cross-sectional shapes may also be utilized, including but not limited to, square, rectangular, triangular, pentagonal, and octagonal depending on the manufacturing technique. Theanchor 112 may be comprised of stainless steel, platinum, Nitinol, Elgiloy or other materials standardly used in the industry. Theanchor 112 may also comprise antibiotics, drugs that prevent the LAA pericardium wall from bleeding, ePTFE, any variety of materials which facilitate cellular in-growth, hydrogel, anticoagulants, fibrin hairs and/or other pharmaceuticals. Theanchor 112 may further include barbs, points, bristles, spurs, screws, hooks, pins, sutures, adhesives, pledgets, or other means of attachment. - Illustrated in
FIG. 22 , the method of the present invention comprises advancing theanchor 112 in the contracted first position (FIG. 21A ) through theinner sheath 98 using theanchor cable 122 and thedelivery wire 100, wherein theanchor 112 is further advanced through thesmall hole 110 to penetrate the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106 to extend into thepericardial space 68. Thedelivery wire 100 may then be retracted, allowing thesecond coil 116 of theanchor 112 to self-expand from the contracted first position to the deployed second position within thepericardial space 108. While thesecond coil 116 of theanchor 112 is in the deployed second position, theshaft 118 and thefirst coil 114 of theanchor 112 remain temporarily in the contracted first position. - Illustrated in
FIG. 23 , the method of the present invention comprises retracting theinner sheath 98 adjacent theLAA wall 106, along with thedelivery wire 100, to allow thefirst coil 114 of theanchor 112 to self-expand from the contracted first position to a partially deployed second position within theoccluder device 120. Theoccluder device 120 remains inside theouter sheath 96 adjacent theLAA wall 106. Theshaft 118 resides inside the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106. Thesecond coil 116 of theanchor 112 remains in the deployed second position within thepericardial space 108, wherein thefirst coil 114 of theanchor 112 is in the partially deployed second position within theoccluder device 120. Alternatively, theanchor 112 andoccluder device 120 may be integral, wherein theoccluder device 120 may be a coil occluder device. Thus, theintegral anchor 112 andoccluder device 120 may be advanced together through theinner sheath 98, wherein theanchor 112 is implanted in theLAA wall 106 using thesystem 90 of the present invention described above. - Illustrated in
FIG. 24 , the method of the present invention comprises retracting theouter sheath 96 to allow theoccluder device 120 to expand inside theLAA 104. Moreover, retracting theouter sheath 96 allows thefirst coil 114 of theanchor 112 to fully expand into the deployed second position within theoccluder device 120. Thus, theshaft 118 of theanchor 112 may extend through the hole in the distal end of theoccluder device 120, wherein the distal end of theoccluder device 120 pinches down on theshaft 118. Furthermore, thefirst coil 114 of theanchor 112 in the deployed second position may pin theoccluder device 120 against theLAA wall 106, wherein theanchor 112 effectively moors theoccluder device 120 inside theLAA 104. At this time the expandedanchor 112 in the deployed second position covers a large surface area and therefore retains theoccluder device 120 in an implanted position within theLAA 104. Moreover, by anchoring theoccluder device 120 via theanchor 112 through all three layers of theLAA wall 106—instead of merely latching onto the thin endocardium layer—the method of the present invention lowers the risk of embolization. Thesecond coil 116 located within thepericardial space 108 may unwind in a clockwise fashion, while thefirst coil 114 located in theLAA 104 may unwind in an reverse-clockwise fashion. Thus, there would be counter-forces acting on the coils, wherein thesecond coil 116 exerts proximal traction and thefirst coil 114 exerts distal traction against opposite sides of theLAA wall 106. Such counter-forces discourage theanchor 112 from unraveling while in the deployed second position within theLAA wall 106. - The
anchor cable 122 remains attached to theanchor 112 and theoccluder cable 124 remains attached to theoccluder device 120 in case problems arise after deployment of theoccluder device 120. If no problems arise and a determination is made that theoccluder device 120 is in an optimal location of theLAA 104, theoccluder cable 124 may be detached from theoccluder device 120 and removed from theLAA 104. Furthermore, theanchor cable 122 may be detached from theanchor 112 and removed from theLAA 104. Thebuddy wire 102 anddelivery wire 100 may also be withdrawn from theLAA 106, leaving theoccluder device 120 anchored securely in theLAA 104 by the method of the present invention. -
FIG. 25 illustrates the method of the present invention if problems arise after deployment of theoccluder device 120. For instance, the method comprises making a determination that theoccluder device 120 is not placed in an optimal location of theLAA 104 after deployment to achieve maximum occlusion. In this situation—prior to release of theoccluder cable 124 from theoccluder device 120 and theanchor cable 122 from theanchor 112—theouter sheath 96 may be advanced over theoccluder device 120, wherein theoccluder device 120 is retracted inside theouter sheath 96 using theoccluder cable 124. Thedelivery wire 100 may be further advanced through theanchor cable 112 andfirst coil 114 of theanchor 112, wherein thefirst coil 114 retracts from the deployed second position to the contracted first position and may be retrieved inside theinner sheath 98. Theouter sheath 96 containing theoccluder device 120 may then be removed from theLAA 104, or theoccluder device 120 may be re-deployed in a more optimal location of theLAA 104. If theoccluder device 120 is removed from theLAA 104, thedelivery wire 100 may be retrieved thereafter, allowing thefirst coil 114 of theanchor 112 to re-expand from the contracted first position to the deployed second position within theLAA 104. Thus, the deployedanchor 112 remains inside theLAA 104 and allows for occlusion of thesmall hole 110 that was created by thepericardial catheter 94 through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of theLAA wall 106. - Illustrated in
FIG. 26 , if a determination is made that optimal placement of theanchor 112 was not achieved, theanchor 112 may be released from theanchor cable 122 and deployed alone within theLAA wall 106. This allows for anew anchor 112 to be placed within theLAA wall 106 using the method cited above for achieving optimal placement of theoccluder device 120 within theLAA 104. On the other hand, if theanchor 112 is initially placed in an optimal location within theLAA wall 106 but there are problems with theoccluder device 120, a second occluder device may be advanced using theinner sheath 98 and deployed within theLAA 104 using the method cited above. Thus, the method of the present invention allows an interventional cardiologist to quickly and cost-effectively implant theoccluder device 120 into theLAA 104 usinganchor 112, safely retrieve or re-deploy theoccluder device 120 if initial placement was improper or if complications arise, with an option to re-implant a new occluder device and new anchor in an optimal location of theLAA 104. After optimal placement of theoccluder device 120 within theLAA 104 is achieved, thedelivery wire 100 and thebuddy wire 102 may be removed from theLAA 104.
Claims (20)
1. An anchoring system for implanting an occluder device within a left atrial appendage (LAA) of a heart, comprising:
an outer sheath;
a pericardial catheter;
an occluder device for a LAA;
an anchor;
a contracted first position of the anchor;
a deployed second position of the anchor;
the outer sheath inserted into the LAA through a left atrium proper of the heart;
the pericardial catheter advanced through the outer sheath into the LAA;
the pericardial catheter perforates an inner endocardium layer, middle myocardium layer, and outer epicardium layer of an LAA wall of the heart;
the pericardial catheter creates a small hole through the LAA wall into a pericardial space;
a delivery wire and/or a buddy wire advanced through the pericardial catheter into the pericardial space of the heart through the small hole;
the pericardial catheter removed from the LAA through the outer sheath;
the occluder device and the anchor advanced into the LAA using the delivery wire, wherein the anchor is in the contracted first position;
the anchor in the contracted first position is advanced through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall using the delivery wire;
the anchor in the contracted first position is advanced into the pericardial space through the small hole in the LAA wall using the delivery wire;
the anchor is expanded in the pericardial space from the contracted first position to the deployed second position; and
the occluder device is released from the outer sheath to occlude the LAA;
wherein the anchor moors the occluder device to the LAA wall.
2. The anchoring system of claim 1 , further comprising:
the occluder device is detached from the anchor;
the anchor is left implanted in the LAA wall of the LAA;
the occluder device is retrieved;
a new anchor is inserted into the LAA;
the new anchor is implanted at another location in the LAA wall, wherein the new anchor is advanced through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall;
the occluder device is released from the outer sheath to occlude the LAA; and
wherein the occluder device is moored to the LAA wall via the new anchor.
3. The anchoring system of claim 1 , further comprising:
the occluder device is detached from the anchor;
the anchor is left implanted in the LAA wall of the LAA;
the occluder device is retrieved;
a new occluder device is inserted into the LAA via the outer sheath;
the new occluder device is attached to the anchor implanted in the LAA wall of the LAA;
the new occluder device is released from the outer sheath to occlude the LAA; and
wherein the occluder device is moored to the LAA wall via the new anchor.
4. The anchoring system of claim 1 , wherein the anchor has a diameter of approximately 1-5 mm in the contracted first position and a diameter of approximately 2-20 mm in the deployed second position.
5. The anchoring system of claim 1 , wherein the anchor is self-expanding.
6. The anchoring system of claim 1 , wherein the anchor comprises a sheave shape.
7. The anchoring system of claim 6 , wherein the anchor comprises a first half and a second half, wherein the first half is connected to the second half by a shaft.
8. The anchoring system of claim 7 , wherein the first half is inside the LAA, the second half is inside the pericardial space, and the shaft is through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall to moor the occluder device within the LAA.
9. The anchoring system of claim 8 , wherein the anchor comprises a coil.
10. The anchoring system of claim 9 , wherein the anchor comprises a first coil and a second coil, wherein the first coil is connected to the second coil by a shaft.
11. The anchoring system of claim 10 , wherein the first coil is inside the LAA, the second coil is inside the pericardial space, and the shaft is through the inner endocardium layer, middle myocardium layer, and outer epicardium layer of the LAA wall to moor the occluder device within the LAA.
12. An anchor for implanting an occluder device within a left atrial appendage (LAA) of a heart, comprising:
an anchor comprising a contracted first position and a deployed second position;
wherein the anchor penetrates an inner endocardium layer, a middle myocardium layer, and an outer epicardium layer of a LAA wall;
wherein a portion of the anchor self-expands from a contracted first position to a deployed second position within a pericardial space of the heart;
wherein the occluder device is moored to the LAA wall via the anchor.
13. The anchor of claim 12 , further comprising:
wherein the occluder device may be detached from the anchor;
wherein the anchor remains implanted through the LAA wall without harming the patient.
14. The anchor of claim 12 , further comprising:
wherein the anchor retracts from the deployed second position to the contracted first position;
wherein the anchor re-penetrates at a different location of the LAA wall the inner endocardium layer, the middle myocardium layer, and the outer epicardium layer of the LAA wall;
wherein a portion of the anchor self-expands from a contracted first position to a deployed second position within the pericardial space of the heart; and
wherein the occluder device is moored to the LAA wall via the anchor at a new location.
15. The anchor system of claim 12 , wherein the anchor has a diameter of approximately 1-5 mm in the contracted first position and a diameter of approximately 2-20 mm in the deployed second position.
16. The anchoring system of claim 15 , wherein the anchor comprises a sheave shape.
17. The anchoring system of claim 15 , wherein the anchor comprises a coil.
18. A method of anchoring an occluder device within a left atrial appendage (LAA) of a heart, comprising:
providing an anchoring system for implanting the occluder device within the LAA, wherein the anchoring system comprises:
a) an outer sheath;
b) a pericardial catheter;
c) an occluder device for a LAA;
d) an anchor;
e) a plurality of self-expanding anchor tines or a sheave shape or a coil;
f) a contracted first position of the anchor; and
g) a deployed second position of the anchor;
inserting the outer sheath into the LAA through a left atrium proper of the heart;
advancing the pericardial catheter through the outer sheath into the LAA;
perforating an inner endocardium layer, a middle myocardium layer, and an outer epicardium layer of an LAA wall of the heart using the pericardial catheter;
creating a small hole through the LAA wall into a pericardial space using the pericardial catheter;
advancing a delivery wire and/or a buddy wire through the pericardial catheter into the pericardial space of the heart through the small hole;
removing the pericardial catheter from the LAA through the outer sheath;
advancing the occluder device and anchor into the LAA using the delivery wire, wherein the anchor is in the contracted first position;
advancing the anchor in the contracted first position through the inner endocardium layer, the middle myocardium layer, and the outer epicardium layer of the LAA wall using the delivery wire;
further advancing the anchor in the contracted first position into the pericardial space through the small hole in the LAA wall using the delivery wire;
expanding the anchor from the contracted first position to the deployed second position; and
releasing the occluder device from the outer sheath to occlude the LAA;
wherein the occluder device is moored to the LAA wall via the anchor.
19. The method of claim 18 , further comprising:
detaching the occluder device from the anchor;
leaving the anchor implanted in the LAA wall of the LAA;
retrieving the occluder device inside the outer sheath;
inserting a new occluder device in the outer sheath;
implanting the new occluder device in the LAA using the anchor;
releasing the occluder device from the outer sheath to occlude the LAA; and
removing the delivery wire, buddy wire, and outer sheath from the LAA.
20. The method of claim 18 , further comprising:
retrieving the occluder device inside the outer sheath;
removing the anchor from the LAA wall, wherein the anchor retracts from the deployed second position to the contracted first position;
advancing the anchor through the inner endocardium layer, the middle myocardium layer, and the outer epicardium layer at a different location of the LAA wall; and
releasing the occluder device from the outer sheath to occlude the LAA.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/819,724 US20170035433A1 (en) | 2015-08-06 | 2015-08-06 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
PCT/US2016/044005 WO2017023606A1 (en) | 2015-08-06 | 2016-07-26 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
US15/292,975 US10143478B2 (en) | 2015-08-06 | 2016-10-13 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
US16/177,605 US11109868B2 (en) | 2015-08-06 | 2018-11-01 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/819,724 US20170035433A1 (en) | 2015-08-06 | 2015-08-06 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2016/044005 Continuation-In-Part WO2017023606A1 (en) | 2015-08-06 | 2016-07-26 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2016/044005 Continuation WO2017023606A1 (en) | 2015-08-06 | 2016-07-26 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
US15/292,975 Continuation-In-Part US10143478B2 (en) | 2015-08-06 | 2016-10-13 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170035433A1 true US20170035433A1 (en) | 2017-02-09 |
Family
ID=57943483
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/819,724 Abandoned US20170035433A1 (en) | 2015-08-06 | 2015-08-06 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
US15/292,975 Active 2035-11-25 US10143478B2 (en) | 2015-08-06 | 2016-10-13 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
US16/177,605 Active 2036-01-21 US11109868B2 (en) | 2015-08-06 | 2018-11-01 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/292,975 Active 2035-11-25 US10143478B2 (en) | 2015-08-06 | 2016-10-13 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
US16/177,605 Active 2036-01-21 US11109868B2 (en) | 2015-08-06 | 2018-11-01 | Left atrial appendage occluder device anchoring system, anchor, and method of attachment |
Country Status (2)
Country | Link |
---|---|
US (3) | US20170035433A1 (en) |
WO (1) | WO2017023606A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190008495A1 (en) * | 2015-12-31 | 2019-01-10 | Lifetech Scientific (Shenzhen) Co., Ltd. | Left atrial appendage occluder |
CN109567891A (en) * | 2017-09-29 | 2019-04-05 | 上海微创医疗器械(集团)有限公司 | Occluder for left auricle and left atrial appendage occlusion device |
US10918392B2 (en) | 2018-01-26 | 2021-02-16 | Syntheon 2.0, LLC | Left atrial appendage clipping device and methods for clipping the LAA |
US10925615B2 (en) | 2019-05-03 | 2021-02-23 | Syntheon 2.0, LLC | Recapturable left atrial appendage clipping device and methods for recapturing a left atrial appendage clip |
US11134934B2 (en) * | 2018-09-13 | 2021-10-05 | Transmural Systems Llc | Devices and methods for closing openings in tissue structures |
US11484303B2 (en) | 2014-12-02 | 2022-11-01 | 4Tech Inc. | Off-center tissue anchors |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105246540A (en) | 2013-03-13 | 2016-01-13 | 阿龙·V·卡普兰 | Devices and methods for excluding left atrial appendage |
US10405866B2 (en) | 2014-04-25 | 2019-09-10 | Flow MedTech, Inc | Left atrial appendage occlusion device |
CA2999169A1 (en) | 2014-09-19 | 2016-03-24 | Flow Medtech, Inc. | Left atrial appendage occlusion device delivery system |
EP3531926A2 (en) | 2016-10-27 | 2019-09-04 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
EP3459469A1 (en) | 2017-09-23 | 2019-03-27 | Universität Zürich | Medical occluder device |
CN107595347B (en) * | 2017-09-25 | 2019-11-26 | 潘湘斌 | A kind of the left atrial appendage occlusion device assembly and its interventional method of repeatable folding and unfolding |
US10952741B2 (en) * | 2017-12-18 | 2021-03-23 | Boston Scientific Scimed, Inc. | Occlusive device with expandable member |
WO2019136223A1 (en) * | 2018-01-04 | 2019-07-11 | Boston Scientific Scimed, Inc. | Cardiac closure device with a tissue ingrowth member |
EP3883483A1 (en) | 2019-03-25 | 2021-09-29 | Laminar, Inc. | Devices and systems for treating the left atrial appendage |
JP2022549717A (en) | 2019-09-26 | 2022-11-28 | ウニベルシタット チューリッヒ | left atrial appendage closure device |
US20220015748A1 (en) * | 2020-07-17 | 2022-01-20 | Nextern Innovation, Llc | Systems and methods for minimally invasive delivery and in vivo creation of biomaterial structures |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060212047A1 (en) * | 2001-09-06 | 2006-09-21 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
US20080015635A1 (en) * | 2006-06-09 | 2008-01-17 | Daniel Olsen | Single disc occlusionary patent foramen ovale closure device |
US20100211046A1 (en) * | 2009-02-18 | 2010-08-19 | Aga Medical Corporation | Medical device with stiffener wire for occluding vascular defects |
US20130317541A1 (en) * | 2012-05-24 | 2013-11-28 | Lawrence Livermore National Security, Llc | Device and method for treatment of openings in vascular and septal walls |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7279007B2 (en) * | 1999-08-09 | 2007-10-09 | Cardioklnetix, Inc. | Method for improving cardiac function |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6689150B1 (en) * | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
US20060247672A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
US20110178539A1 (en) * | 2008-07-11 | 2011-07-21 | Holmes Jr David R | Left atrial appendage occlusion devices |
US8828051B2 (en) * | 2010-07-02 | 2014-09-09 | Pfm Medical Ag | Left atrial appendage occlusion device |
EP2877104A4 (en) * | 2012-07-26 | 2016-03-30 | Univ Louisville Res Found | Atrial appendage closure device and related methods |
CN105246540A (en) | 2013-03-13 | 2016-01-13 | 阿龙·V·卡普兰 | Devices and methods for excluding left atrial appendage |
-
2015
- 2015-08-06 US US14/819,724 patent/US20170035433A1/en not_active Abandoned
-
2016
- 2016-07-26 WO PCT/US2016/044005 patent/WO2017023606A1/en active Application Filing
- 2016-10-13 US US15/292,975 patent/US10143478B2/en active Active
-
2018
- 2018-11-01 US US16/177,605 patent/US11109868B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060212047A1 (en) * | 2001-09-06 | 2006-09-21 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
US20080015635A1 (en) * | 2006-06-09 | 2008-01-17 | Daniel Olsen | Single disc occlusionary patent foramen ovale closure device |
US20100211046A1 (en) * | 2009-02-18 | 2010-08-19 | Aga Medical Corporation | Medical device with stiffener wire for occluding vascular defects |
US20130317541A1 (en) * | 2012-05-24 | 2013-11-28 | Lawrence Livermore National Security, Llc | Device and method for treatment of openings in vascular and septal walls |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11484303B2 (en) | 2014-12-02 | 2022-11-01 | 4Tech Inc. | Off-center tissue anchors |
US11497485B2 (en) | 2014-12-02 | 2022-11-15 | 4Tech Inc. | Off-center tissue anchors |
US20190008495A1 (en) * | 2015-12-31 | 2019-01-10 | Lifetech Scientific (Shenzhen) Co., Ltd. | Left atrial appendage occluder |
US11253241B2 (en) * | 2015-12-31 | 2022-02-22 | Lifetech Scientific (Shenzhen) Co., Ltd. | Left atrial appendage occluder |
CN109567891A (en) * | 2017-09-29 | 2019-04-05 | 上海微创医疗器械(集团)有限公司 | Occluder for left auricle and left atrial appendage occlusion device |
US10918392B2 (en) | 2018-01-26 | 2021-02-16 | Syntheon 2.0, LLC | Left atrial appendage clipping device and methods for clipping the LAA |
US11191547B2 (en) | 2018-01-26 | 2021-12-07 | Syntheon 2.0, LLC | Left atrial appendage clipping device and methods for clipping the LAA |
US11712249B2 (en) | 2018-01-26 | 2023-08-01 | Syntheon 2.0, LLC | Left atrial appendage clipping device and methods for clipping the LAA |
US11134934B2 (en) * | 2018-09-13 | 2021-10-05 | Transmural Systems Llc | Devices and methods for closing openings in tissue structures |
US10925615B2 (en) | 2019-05-03 | 2021-02-23 | Syntheon 2.0, LLC | Recapturable left atrial appendage clipping device and methods for recapturing a left atrial appendage clip |
Also Published As
Publication number | Publication date |
---|---|
US11109868B2 (en) | 2021-09-07 |
WO2017023606A1 (en) | 2017-02-09 |
US10143478B2 (en) | 2018-12-04 |
US20190069901A1 (en) | 2019-03-07 |
US20170035434A1 (en) | 2017-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11109868B2 (en) | Left atrial appendage occluder device anchoring system, anchor, and method of attachment | |
US11786256B2 (en) | Devices and methods for excluding the left atrial appendage | |
US20240074766A1 (en) | Devices and methods for excluding the left atrial appendage | |
US10617425B2 (en) | Devices and methods for excluding the left atrial appendage | |
US11426172B2 (en) | Devices and methods for excluding the left atrial appendage | |
US20200054343A1 (en) | Inflatable anchoring structure for implant and delivery system | |
US20160095603A1 (en) | Device for preventing clot migraton from left atrial appendage | |
US20130338686A1 (en) | Apparatus and methods for excluding the left atrial appendage | |
US20090099596A1 (en) | Closure device for left atrial appendage | |
EP1175867A2 (en) | Defect occluder release assembly and method | |
JP7366933B2 (en) | Devices and methods for eliminating the left atrial appendage | |
JP2008519653A (en) | Filter sending system | |
JP2015534887A (en) | Space filling equipment | |
WO2010081041A1 (en) | Medical device for modification of left atrial appendage and related systems and methods | |
US20230032647A1 (en) | Devices and methods for excluding the left atrial appendage | |
WO2017066197A1 (en) | Devices and methods for excluding the left atrial appendage | |
EP3355802B1 (en) | Endo-cameral closure device | |
CN111107795A (en) | Frustoconical hemostatic sealing element | |
US20210137528A1 (en) | Left atrial appendage occlusion methods and devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |